{"id": "BioInfer.d645.s0_BioInfer.d645.s0.p0", "text": "The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "text_with_entity_marker": "The monomeric [E1]actin-binding protein[/E1], profilin, is a key regulator of [E2]actin[/E2]-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[14, 35]], "entity_1_idx_in_text_with_entity_marker": [18, 39], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d645.s0_BioInfer.d645.s0.p1", "text": "The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "text_with_entity_marker": "The monomeric [E1]actin-binding protein[/E1], [E2]profilin[/E2], is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[14, 35]], "entity_1_idx_in_text_with_entity_marker": [18, 39], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d645.s0_BioInfer.d645.s0.p2", "text": "The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "text_with_entity_marker": "The monomeric actin-binding protein, [E1]profilin[/E1], is a key regulator of [E2]actin[/E2]-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p0", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p1", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p2", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p3", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, [E1]MEC2[/E1] and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC2", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p4", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, [E1]MEC1[/E1], [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p5", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], [E2]RAD24[/E2], MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p6", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], [E2]RAD17[/E2], RAD24, MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p7", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p8", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p9", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, [E2]RAD24[/E2], MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p10", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p11", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p12", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p13", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p14", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, [E1]MEC1[/E1], MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p0", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "[E1]MLL[/E1] is fused in-frame to a different exon of [E2]CBP[/E2] in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p1", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "[E1]MLL[/E1] is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[256, 259]], "entity_2_idx_in_text_with_entity_marker": [269, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p2", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "[E1]MLL[/E1] is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the [E2]CREB[/E2] binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CREB", "entity_2_idx": [[211, 215]], "entity_2_idx_in_text_with_entity_marker": [224, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p3", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "[E1]MLL[/E1] is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of [E2]MLL[/E2] fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MLL", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p4", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "[E1]MLL[/E1] is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, [E2]methyltransferase[/E2] homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "methyltransferase", "entity_2_idx": [[118, 135]], "entity_2_idx_in_text_with_entity_marker": [131, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p5", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of [E1]CBP[/E1] in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[256, 259]], "entity_2_idx_in_text_with_entity_marker": [269, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p6", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of [E1]CBP[/E1] in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the [E2]CREB[/E2] binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CREB", "entity_2_idx": [[211, 215]], "entity_2_idx_in_text_with_entity_marker": [224, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p7", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of [E1]CBP[/E1] in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of [E2]MLL[/E2] fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MLL", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p8", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of [E1]CBP[/E1] in two patients producing chimeric proteins containing the AT-hooks, [E2]methyltransferase[/E2] homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "methyltransferase", "entity_2_idx": [[118, 135]], "entity_2_idx_in_text_with_entity_marker": [131, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p9", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the [E1]CREB[/E1] binding domain or to the bromodomain of [E2]CBP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[211, 215]], "entity_1_idx_in_text_with_entity_marker": [215, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[256, 259]], "entity_2_idx_in_text_with_entity_marker": [269, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p10", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of [E1]MLL[/E1] fused to the CREB binding domain or to the bromodomain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[256, 259]], "entity_2_idx_in_text_with_entity_marker": [269, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p11", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, [E1]methyltransferase[/E1] homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "methyltransferase", "entity_1_idx": [[118, 135]], "entity_1_idx_in_text_with_entity_marker": [122, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[256, 259]], "entity_2_idx_in_text_with_entity_marker": [269, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p12", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of [E1]MLL[/E1] fused to the [E2]CREB[/E2] binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLL", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[211, 215]], "entity_2_idx_in_text_with_entity_marker": [224, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p13", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, [E1]methyltransferase[/E1] homology domain, and transcriptional repression domain of MLL fused to the [E2]CREB[/E2] binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "methyltransferase", "entity_1_idx": [[118, 135]], "entity_1_idx_in_text_with_entity_marker": [122, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[211, 215]], "entity_2_idx_in_text_with_entity_marker": [224, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d427.s0_BioInfer.d427.s0.p14", "text": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.", "text_with_entity_marker": "MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, [E1]methyltransferase[/E1] homology domain, and transcriptional repression domain of [E2]MLL[/E2] fused to the CREB binding domain or to the bromodomain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "methyltransferase", "entity_1_idx": [[118, 135]], "entity_1_idx_in_text_with_entity_marker": [122, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MLL", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d82.s0_BioInfer.d82.s0.p0", "text": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.", "text_with_entity_marker": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the [E1]cofilin/ADF[/E1] family of [E2]actin[/E2]-severing proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin/ADF", "entity_1_idx": [[178, 189]], "entity_1_idx_in_text_with_entity_marker": [182, 193], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[200, 205]], "entity_2_idx_in_text_with_entity_marker": [213, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d82.s0_BioInfer.d82.s0.p1", "text": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.", "text_with_entity_marker": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the [E1]twinstar[/E1] locus, a gene that encodes a Drosophila member of the cofilin/ADF family of [E2]actin[/E2]-severing proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "twinstar", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[200, 205]], "entity_2_idx_in_text_with_entity_marker": [213, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d82.s0_BioInfer.d82.s0.p2", "text": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.", "text_with_entity_marker": "A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the [E1]twinstar[/E1] locus, a gene that encodes a Drosophila member of the [E2]cofilin/ADF[/E2] family of actin-severing proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "twinstar", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cofilin/ADF", "entity_2_idx": [[178, 189]], "entity_2_idx_in_text_with_entity_marker": [191, 202], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p0", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], myosin, [E2]filamin[/E2], and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "filamin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p1", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, [E1]filamin[/E1], and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "filamin", "entity_1_idx": [[111, 118]], "entity_1_idx_in_text_with_entity_marker": [115, 122], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p2", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, [E1]myosin[/E1], [E2]filamin[/E2], and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "filamin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p3", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], myosin, filamin, and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p4", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], [E2]myosin[/E2], filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p5", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, [E1]myosin[/E1], filamin, and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s1_BioInfer.d502.s1.p0", "text": "The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.", "text_with_entity_marker": "The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a [E1]talin[/E1] mediated mechanism for the attachment of [E2]actin[/E2] filaments to the cell surfaces in the cleavage furrow.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s1_BioInfer.d502.s1.p1", "text": "The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.", "text_with_entity_marker": "The presence of [E1]filamin[/E1] in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of [E2]actin[/E2] filaments to the cell surfaces in the cleavage furrow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "filamin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s1_BioInfer.d502.s1.p2", "text": "The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.", "text_with_entity_marker": "The presence of [E1]filamin[/E1] in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a [E2]talin[/E2] mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "filamin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s0_BioInfer.d652.s0.p0", "text": "The N-terminal talin polypeptide eventually disrupted actin stress fibres whereas the C-terminal polypeptide was without effect.", "text_with_entity_marker": "The N-terminal [E1]talin[/E1] polypeptide eventually disrupted [E2]actin[/E2] stress fibres whereas the C-terminal polypeptide was without effect.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s1_BioInfer.d652.s1.p0", "text": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.", "text_with_entity_marker": "The Pro1176 to Thr substitution found in [E1]talin[/E1] from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind [E2]actin[/E2] or vinculin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s1_BioInfer.d652.s1.p1", "text": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.", "text_with_entity_marker": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind [E1]actin[/E1] or [E2]vinculin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[138, 143]], "entity_1_idx_in_text_with_entity_marker": [142, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s1_BioInfer.d652.s1.p2", "text": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.", "text_with_entity_marker": "The Pro1176 to Thr substitution found in [E1]talin[/E1] from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or [E2]vinculin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p0", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p1", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "IL-2", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p2", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and [E2]c-Jun N-terminal kinase[/E2], but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[288, 311]], "entity_2_idx_in_text_with_entity_marker": [301, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p3", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p4", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p5", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of [E2]IL-2[/E2] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p6", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p7", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p8", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p9", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E1]IL-2[/E1] production in Jurkat cells and that the transcription factor [E2]AP-1[/E2] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-2", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p50", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p51", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E1]MAPK[/E1], may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[329, 333]], "entity_1_idx_in_text_with_entity_marker": [333, 337], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p52", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E1]extracellular signal regulated protein kinase[/E1] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal regulated protein kinase", "entity_1_idx": [[238, 283]], "entity_1_idx_in_text_with_entity_marker": [242, 287], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p53", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p54", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p55", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E1]p38[/E1] MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p38", "entity_1_idx": [[325, 328]], "entity_1_idx_in_text_with_entity_marker": [329, 332], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p56", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p57", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p58", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p59", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d648.s0_BioInfer.d648.s0.p0", "text": "The multifunctional protein profilin is one of the most abundant proteins in the cytoplasm and is thought to regulate actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The multifunctional protein [E1]profilin[/E1] is one of the most abundant proteins in the cytoplasm and is thought to regulate [E2]actin[/E2] assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p30", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, [E2]hnRNP[/E2], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hnRNP", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p31", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], [E2]embryonic beta-tubulin[/E2], hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "embryonic beta-tubulin", "entity_2_idx": [[70, 92]], "entity_2_idx_in_text_with_entity_marker": [83, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p32", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p33", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase ([E2]PIMT[/E2]), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PIMT", "entity_2_idx": [[142, 146]], "entity_2_idx_in_text_with_entity_marker": [155, 159], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p34", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, [E2]protein L-isoaspartyl methyltransferase[/E2] (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "protein L-isoaspartyl methyltransferase", "entity_2_idx": [[101, 140]], "entity_2_idx_in_text_with_entity_marker": [114, 153], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p35", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], [E2]hnRNP[/E2], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hnRNP", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p36", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p37", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], protein L-isoaspartyl methyltransferase ([E2]PIMT[/E2]), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PIMT", "entity_2_idx": [[142, 146]], "entity_2_idx_in_text_with_entity_marker": [155, 159], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p38", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], [E2]protein L-isoaspartyl methyltransferase[/E2] (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "protein L-isoaspartyl methyltransferase", "entity_2_idx": [[101, 140]], "entity_2_idx_in_text_with_entity_marker": [114, 153], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p39", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p60", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p61", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p62", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] ([E2]F[/E2]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[86, 87]], "entity_2_idx_in_text_with_entity_marker": [99, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p63", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p64", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p65", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p66", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p67", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), [E2]fusion[/E2] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "fusion", "entity_2_idx": [[78, 84], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p68", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p69", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein ([E2]P[/E2]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[62, 63]], "entity_2_idx_in_text_with_entity_marker": [75, 76], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p10", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- [E1]catenin[/E1] complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p11", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- [E1]catenin[/E1] complexes, one composed of [E2]E-cadherin[/E2], alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p12", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- [E1]catenin[/E1] complexes, one composed of E-cadherin, [E2]alpha-catenin[/E2] and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenin", "entity_1_idx": [[89, 96]], "entity_1_idx_in_text_with_entity_marker": [93, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p13", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different [E1]E-cadherin[/E1]- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of [E2]E-cadherin[/E2], alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[185, 195]], "entity_2_idx_in_text_with_entity_marker": [198, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p14", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different [E1]E-cadherin[/E1]- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[215, 226]], "entity_2_idx_in_text_with_entity_marker": [228, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p15", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different [E1]E-cadherin[/E1]- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p16", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different [E1]E-cadherin[/E1]- catenin complexes, one composed of [E2]E-cadherin[/E2], alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p17", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different [E1]E-cadherin[/E1]- catenin complexes, one composed of E-cadherin, [E2]alpha-catenin[/E2] and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[77, 87]], "entity_1_idx_in_text_with_entity_marker": [81, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p18", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of [E1]E-cadherin[/E1], alpha-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[185, 195]], "entity_1_idx_in_text_with_entity_marker": [189, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[215, 226]], "entity_2_idx_in_text_with_entity_marker": [228, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p19", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[185, 195]], "entity_1_idx_in_text_with_entity_marker": [189, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d494.s0_BioInfer.d494.s0.p0", "text": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.", "text_with_entity_marker": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of [E1]gelsolin[/E1] and profilin with [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[164, 169]], "entity_2_idx_in_text_with_entity_marker": [177, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d494.s0_BioInfer.d494.s0.p1", "text": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.", "text_with_entity_marker": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and [E1]profilin[/E1] with [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[150, 158]], "entity_1_idx_in_text_with_entity_marker": [154, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[164, 169]], "entity_2_idx_in_text_with_entity_marker": [177, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d494.s0_BioInfer.d494.s0.p2", "text": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.", "text_with_entity_marker": "Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of [E1]gelsolin[/E1] and [E2]profilin[/E2] with actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p0", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p1", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p2", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p3", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p4", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p5", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p6", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p7", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p8", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p9", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p40", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p41", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p42", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p43", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p44", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein ([E2]P[/E2]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[200, 201]], "entity_2_idx_in_text_with_entity_marker": [213, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p45", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p46", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p47", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p48", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p49", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p50", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p51", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p52", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p53", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E1]F0[/E1]) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[302, 304]], "entity_1_idx_in_text_with_entity_marker": [306, 308], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p54", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E1]fusion protein[/E1] (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion protein", "entity_1_idx": [[286, 300]], "entity_1_idx_in_text_with_entity_marker": [290, 304], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p55", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E1]F0[/E1] and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[335, 337]], "entity_1_idx_in_text_with_entity_marker": [339, 341], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p56", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E1]F0[/E1] and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[335, 337]], "entity_1_idx_in_text_with_entity_marker": [339, 341], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p57", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p58", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p59", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p10", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in [E1]cofilin[/E1] and ADF but not in actin, [E2]ADF[/E2] and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p11", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in [E1]cofilin[/E1] and [E2]ADF[/E2] but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p12", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, [E1]ADF[/E1] and/or cofilin may be responsible for the nuclear import of [E2]actin[/E2] in myogenic cells under certain conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p13", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and [E1]ADF[/E1] but not in actin, ADF and/or cofilin may be responsible for the nuclear import of [E2]actin[/E2] in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s0_BioInfer.d78.s0.p14", "text": "As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "text_with_entity_marker": "As a nuclear transport signal sequence exists in cofilin and [E1]ADF[/E1] but not in actin, [E2]ADF[/E2] and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p0", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, [E1]ADF[/E1] and [E2]cofilin[/E2], are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[131, 134]], "entity_1_idx_in_text_with_entity_marker": [135, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[139, 146]], "entity_2_idx_in_text_with_entity_marker": [152, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p1", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and [E1]cofilin[/E1], are transported into nuclei of cultured myogenic cells to form rod structures there together with [E2]actin[/E2], when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[139, 146]], "entity_1_idx_in_text_with_entity_marker": [143, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p2", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two [E1]actin-binding proteins[/E1] of low molecular weight with different functional activity, ADF and [E2]cofilin[/E2], are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[48, 70]], "entity_1_idx_in_text_with_entity_marker": [52, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[139, 146]], "entity_2_idx_in_text_with_entity_marker": [152, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p3", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, [E1]ADF[/E1] and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with [E2]actin[/E2], when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[131, 134]], "entity_1_idx_in_text_with_entity_marker": [135, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p4", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two [E1]actin-binding proteins[/E1] of low molecular weight with different functional activity, [E2]ADF[/E2] and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[48, 70]], "entity_1_idx_in_text_with_entity_marker": [52, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ADF", "entity_2_idx": [[131, 134]], "entity_2_idx_in_text_with_entity_marker": [144, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p10", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, [E1]histone[/E1] H4 in nucleosomes was acetylated to a much greater extent than was histone [E2]H3[/E2], whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[236, 238]], "entity_2_idx_in_text_with_entity_marker": [249, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p11", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone [E1]H3[/E1]: with the purified acetylase, [E2]histone[/E2] H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[120, 122]], "entity_1_idx_in_text_with_entity_marker": [124, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[153, 160]], "entity_2_idx_in_text_with_entity_marker": [166, 173], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p12", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified [E1]acetylase[/E1], [E2]histone[/E2] H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acetylase", "entity_1_idx": [[142, 151]], "entity_1_idx_in_text_with_entity_marker": [146, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[153, 160]], "entity_2_idx_in_text_with_entity_marker": [166, 173], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p13", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, [E1]histone[/E1] H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous [E2]acetylase(s)[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "acetylase(s)", "entity_2_idx": [[301, 313]], "entity_2_idx_in_text_with_entity_marker": [314, 326], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p14", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of [E1]histone[/E1] H3: with the purified acetylase, [E2]histone[/E2] H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[112, 119]], "entity_1_idx_in_text_with_entity_marker": [116, 123], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[153, 160]], "entity_2_idx_in_text_with_entity_marker": [166, 173], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p15", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, [E1]histone[/E1] [E2]H4[/E2] in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p16", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, [E1]histone[/E1] H4 in nucleosomes was acetylated to a much greater extent than was [E2]histone[/E2] H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[153, 160]], "entity_1_idx_in_text_with_entity_marker": [157, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[228, 235]], "entity_2_idx_in_text_with_entity_marker": [241, 248], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p17", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of [E1]histone[/E1] H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone [E2]H3[/E2], whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[236, 238]], "entity_2_idx_in_text_with_entity_marker": [249, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p18", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of [E1]histone[/E1] H4 versus acetylation of histone [E2]H3[/E2]: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[120, 122]], "entity_2_idx_in_text_with_entity_marker": [133, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d647.s0_BioInfer.d647.s0.p19", "text": "The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "text_with_entity_marker": "The most striking difference was in the relative preference for acetylation of [E1]histone[/E1] H4 versus acetylation of histone H3: with the purified [E2]acetylase[/E2], histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "acetylase", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p42", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] [E2]H3[/E2] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[14, 16]], "entity_2_idx_in_text_with_entity_marker": [27, 29], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p43", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total [E2]H3[/E2] and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[69, 71]], "entity_2_idx_in_text_with_entity_marker": [82, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p44", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p45", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p46", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and [E2]H2a[/E2] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2a", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p47", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total [E2]H3[/E2] and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[69, 71]], "entity_2_idx_in_text_with_entity_marker": [82, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p48", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p49", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p50", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p51", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E1]histone[/E1] H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[113, 120]], "entity_1_idx_in_text_with_entity_marker": [117, 124], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s0_BioInfer.d97.s0.p0", "text": "Binding of talin to actin occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.", "text_with_entity_marker": "Binding of [E1]talin[/E1] to [E2]actin[/E2] occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[20, 25]], "entity_2_idx_in_text_with_entity_marker": [33, 38], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s1_BioInfer.d97.s1.p0", "text": "Platelet talin binds to actin in vitro and hence is an actin binding protein.", "text_with_entity_marker": "[E1]Platelet talin[/E1] binds to [E2]actin[/E2] in vitro and hence is an actin binding protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Platelet talin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s1_BioInfer.d97.s1.p1", "text": "Platelet talin binds to actin in vitro and hence is an actin binding protein.", "text_with_entity_marker": "[E1]Platelet talin[/E1] binds to actin in vitro and hence is an [E2]actin binding protein[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Platelet talin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[55, 76]], "entity_2_idx_in_text_with_entity_marker": [68, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d97.s1_BioInfer.d97.s1.p2", "text": "Platelet talin binds to actin in vitro and hence is an actin binding protein.", "text_with_entity_marker": "Platelet talin binds to [E1]actin[/E1] in vitro and hence is an [E2]actin binding protein[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[55, 76]], "entity_2_idx_in_text_with_entity_marker": [68, 89], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p40", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, [E2]histone[/E2] H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[203, 210]], "entity_2_idx_in_text_with_entity_marker": [216, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p41", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four [E2]histone[/E2] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[178, 185]], "entity_2_idx_in_text_with_entity_marker": [191, 198], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p42", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p43", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E2]histone[/E2] H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[287, 294]], "entity_2_idx_in_text_with_entity_marker": [300, 307], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p44", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E2]histone[/E2] H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[272, 279]], "entity_2_idx_in_text_with_entity_marker": [285, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p45", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p46", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p47", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p48", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E2]histone[/E2] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[242, 249]], "entity_2_idx_in_text_with_entity_marker": [255, 262], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p49", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p50", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone [E2]H1[/E2] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[186, 188]], "entity_2_idx_in_text_with_entity_marker": [199, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p51", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] [E2]H1(0)[/E2], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1(0)", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p52", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: [E2]histone[/E2] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[158, 165]], "entity_2_idx_in_text_with_entity_marker": [171, 178], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p53", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p54", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p55", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p56", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p57", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, [E1]histone[/E1] H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[203, 210]], "entity_1_idx_in_text_with_entity_marker": [207, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p58", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p59", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, [E2]histone[/E2] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[257, 264]], "entity_2_idx_in_text_with_entity_marker": [270, 277], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p0", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p1", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin ([E1]E-CD[/E1]) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-CD", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p2", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E1]epithelial cadherin[/E1] (E-CD) and [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial cadherin", "entity_1_idx": [[127, 146]], "entity_1_idx_in_text_with_entity_marker": [131, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p3", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin ([E2]E-CD[/E2]) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p4", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of [E1]beta-catenin[/E1] was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E2]epithelial cadherin[/E2] (E-CD) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epithelial cadherin", "entity_2_idx": [[127, 146]], "entity_2_idx_in_text_with_entity_marker": [140, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s0_BioInfer.d203.s0.p5", "text": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of epithelial cadherin (E-CD) and alpha-catenin.", "text_with_entity_marker": "Expression of beta-catenin was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of [E1]epithelial cadherin[/E1] ([E2]E-CD[/E2]) and alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial cadherin", "entity_1_idx": [[127, 146]], "entity_1_idx_in_text_with_entity_marker": [131, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-CD", "entity_2_idx": [[148, 152]], "entity_2_idx_in_text_with_entity_marker": [161, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p0", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, [E1]alpha-catenin[/E1] was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and [E2]E-CD[/E2] was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p1", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, [E1]alpha-catenin[/E1] was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of [E2]beta-catenin[/E2] and E-CD was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[147, 159]], "entity_2_idx_in_text_with_entity_marker": [160, 172], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d203.s1_BioInfer.d203.s1.p2", "text": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of beta-catenin and E-CD was unchanged between them.", "text_with_entity_marker": "In invasive ductal carcinomas, alpha-catenin was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of [E1]beta-catenin[/E1] and [E2]E-CD[/E2] was unchanged between them.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[147, 159]], "entity_1_idx_in_text_with_entity_marker": [151, 163], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-CD", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p0", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, lactic dehydrogenase, [E1]profilin[/E1], and [E2]actin depolymerizing factor[/E2] levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[87, 114]], "entity_2_idx_in_text_with_entity_marker": [100, 127], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p1", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, [E1]lactic dehydrogenase[/E1], [E2]profilin[/E2], and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "lactic dehydrogenase", "entity_1_idx": [[51, 71]], "entity_1_idx_in_text_with_entity_marker": [55, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[73, 81]], "entity_2_idx_in_text_with_entity_marker": [86, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p2", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, [E1]lactic dehydrogenase[/E1], profilin, and [E2]actin depolymerizing factor[/E2] levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "lactic dehydrogenase", "entity_1_idx": [[51, 71]], "entity_1_idx_in_text_with_entity_marker": [55, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[87, 114]], "entity_2_idx_in_text_with_entity_marker": [100, 127], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p0", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the [E1]UL9[/E1] gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the [E2]UL8[/E2] or UL52 gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p1", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the [E1]UL8[/E1] or [E2]UL52[/E2] gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d120.s0_BioInfer.d120.s0.p2", "text": "By the use of HSV mutants for the UL9 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or UL52 gene used as control.", "text_with_entity_marker": "By the use of HSV mutants for the [E1]UL9[/E1] gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the UL8 or [E2]UL52[/E2] gene used as control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[34, 37]], "entity_1_idx_in_text_with_entity_marker": [38, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[197, 201]], "entity_2_idx_in_text_with_entity_marker": [210, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p0", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human [E1]beta-catenin[/E1] can simultaneously bind to the alpha-catenin/actin complex but does not bind [E2]actin[/E2] directly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[18, 30]], "entity_1_idx_in_text_with_entity_marker": [22, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p1", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human [E1]beta-catenin[/E1] can simultaneously bind to the alpha-catenin/[E2]actin[/E2] complex but does not bind actin directly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[18, 30]], "entity_1_idx_in_text_with_entity_marker": [22, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p2", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human [E1]beta-catenin[/E1] can simultaneously bind to the [E2]alpha-catenin[/E2]/actin complex but does not bind actin directly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[18, 30]], "entity_1_idx_in_text_with_entity_marker": [22, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[62, 75]], "entity_2_idx_in_text_with_entity_marker": [75, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p3", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/[E1]actin[/E1] complex but does not bind [E2]actin[/E2] directly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p4", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human beta-catenin can simultaneously bind to the [E1]alpha-catenin[/E1]/actin complex but does not bind [E2]actin[/E2] directly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[62, 75]], "entity_1_idx_in_text_with_entity_marker": [66, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d509.s0_BioInfer.d509.s0.p5", "text": "Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.", "text_with_entity_marker": "Recombinant human beta-catenin can simultaneously bind to the [E1]alpha-catenin[/E1]/[E2]actin[/E2] complex but does not bind actin directly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[62, 75]], "entity_1_idx_in_text_with_entity_marker": [66, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p20", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p21", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p22", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E2]RAD24[/E2], BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[189, 194]], "entity_2_idx_in_text_with_entity_marker": [202, 207], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p23", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E1]RAD24[/E1], [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[189, 194]], "entity_1_idx_in_text_with_entity_marker": [193, 198], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p24", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, [E1]RAD24[/E1], BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[189, 194]], "entity_1_idx_in_text_with_entity_marker": [193, 198], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p25", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p26", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p27", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p28", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p29", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p40", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p41", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p42", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p43", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p44", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p45", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p46", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p47", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p48", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p49", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p30", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E1]CBP[/E1]/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p31", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E1]CBP[/E1]/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p32", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that [E2]CBP[/E2]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p33", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E1]CBP[/E1]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p34", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E1]CBP[/E1]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p35", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E2]CBP[/E2]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CBP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p36", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E1]CBP[/E1]/p300, and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p37", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that [E2]CBP[/E2]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CBP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p38", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E1]p300[/E1], and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p39", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that CBP/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p9", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that [E1]cofilin[/E1] binds to actin filaments in a 1:1 molar ratio of cofilin to [E2]actin[/E2] monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p10", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that [E1]cofilin[/E1] binds to actin filaments in a 1:1 molar ratio of [E2]cofilin[/E2] to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[132, 139]], "entity_2_idx_in_text_with_entity_marker": [145, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p11", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to [E1]actin[/E1] filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that [E2]cofilin[/E2] increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[182, 189]], "entity_2_idx_in_text_with_entity_marker": [195, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p12", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to [E1]actin[/E1] filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p13", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to [E1]actin[/E1] filaments in a 1:1 molar ratio of cofilin to [E2]actin[/E2] monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p14", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to [E1]actin[/E1] filaments in a 1:1 molar ratio of [E2]cofilin[/E2] to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[132, 139]], "entity_2_idx_in_text_with_entity_marker": [145, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p15", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that [E1]cofilin[/E1] increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[182, 189]], "entity_1_idx_in_text_with_entity_marker": [186, 193], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p16", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to [E1]actin[/E1] monomer in the filament and that [E2]cofilin[/E2] increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[182, 189]], "entity_2_idx_in_text_with_entity_marker": [195, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p17", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of [E1]cofilin[/E1] to actin monomer in the filament and that [E2]cofilin[/E2] increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[132, 139]], "entity_1_idx_in_text_with_entity_marker": [136, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[182, 189]], "entity_2_idx_in_text_with_entity_marker": [195, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p18", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to [E1]actin[/E1] monomer in the filament and that cofilin increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[143, 148]], "entity_1_idx_in_text_with_entity_marker": [147, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d201.s0_BioInfer.d201.s0.p0", "text": "Expression of actin and myosin heavy chain genes in skeletal, cardiac and uterine muscles of young and old rats.", "text_with_entity_marker": "Expression of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] genes in skeletal, cardiac and uterine muscles of young and old rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[24, 42]], "entity_2_idx_in_text_with_entity_marker": [37, 55], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d545.s0_BioInfer.d545.s0.p0", "text": "Smooth muscle talin prepared from chicken gizzard binds to skeletal muscle actin in vitro.", "text_with_entity_marker": "[E1]Smooth muscle talin[/E1] prepared from chicken gizzard binds to [E2]skeletal muscle actin[/E2] in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Smooth muscle talin", "entity_1_idx": [[0, 19]], "entity_1_idx_in_text_with_entity_marker": [4, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[59, 80]], "entity_2_idx_in_text_with_entity_marker": [72, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d684.s0_BioInfer.d684.s0.p0", "text": "The relatively conservative sequence of profilins from yeast, Physarum, Acanthamoeba, echinoid eggs and mammalian cells was found in the N-terminal region, which was suggested to be a common actin-binding region.", "text_with_entity_marker": "The relatively conservative sequence of [E1]profilins[/E1] from yeast, Physarum, Acanthamoeba, echinoid eggs and mammalian cells was found in the N-terminal region, which was suggested to be a common [E2]actin[/E2]-binding region.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[191, 196]], "entity_2_idx_in_text_with_entity_marker": [204, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p0", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]PAC2[/E1] functions with [E2]CIN1[/E2], 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PAC2", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN1", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p1", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]PAC2[/E1] functions with [E2]CIN[/E2]1, 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PAC2", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN", "entity_2_idx": [[45, 48], [57, 58]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p2", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]PAC2[/E1] functions with [E2]CIN[/E2]1, 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PAC2", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN", "entity_2_idx": [[45, 48], [51, 52]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p3", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae PAC2 functions with [E1-E2]CIN[/E1]1[/E2], 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIN", "entity_1_idx": [[45, 48], [57, 58]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN[/E1]1", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p4", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae PAC2 functions with [E1-E2]CIN[/E1]1[/E2], 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIN", "entity_1_idx": [[45, 48], [51, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN[/E1]1", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d526.s0_BioInfer.d526.s0.p5", "text": "Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.", "text_with_entity_marker": "Saccharomyces cerevisiae PAC2 functions with [E1-E2]CIN[/E1-E2]1, 2 and 4 in a pathway leading to normal microtubule stability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CIN", "entity_1_idx": [[45, 48], [51, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CIN", "entity_2_idx": [[45, 48], [57, 58]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p0", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-[E1]G[/E1]-L-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[46, 47]], "entity_1_idx_in_text_with_entity_marker": [50, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p1", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-[E1]L[/E1]-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[48, 49]], "entity_1_idx_in_text_with_entity_marker": [52, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p2", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p3", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p4", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p5", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p6", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E1]4b[/E1] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[103, 105]], "entity_1_idx_in_text_with_entity_marker": [107, 109], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p7", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E1]4b[/E1] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[103, 105]], "entity_1_idx_in_text_with_entity_marker": [107, 109], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p8", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and [E2]4b[/E2] are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "4b", "entity_2_idx": [[103, 105]], "entity_2_idx_in_text_with_entity_marker": [116, 118], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p9", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and [E1]4b[/E1] are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "4b", "entity_1_idx": [[103, 105]], "entity_1_idx_in_text_with_entity_marker": [107, 109], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p50", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-[E2]4b[/E2]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4b", "entity_2_idx": [[41, 43]], "entity_2_idx_in_text_with_entity_marker": [54, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p51", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p52", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p53", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where [E2]N[/E2] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[60, 61]], "entity_2_idx_in_text_with_entity_marker": [73, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p54", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p55", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p56", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p57", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p58", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the [E2]nucleocapsid protein[/E2] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p59", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p80", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p81", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p82", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p83", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the [E2]nucleocapsid protein[/E2] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p84", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p85", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p86", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p87", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p88", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p89", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where [E2]N[/E2] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[60, 61]], "entity_2_idx_in_text_with_entity_marker": [73, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p0", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by [E1]myosin heavy chain[/E1] antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with [E2]non-muscle myosin heavy chain[/E2]; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[85, 103]], "entity_1_idx_in_text_with_entity_marker": [89, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "non-muscle myosin heavy chain", "entity_2_idx": [[240, 269]], "entity_2_idx_in_text_with_entity_marker": [253, 282], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p1", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional [E1]non-muscle myosin heavy chain[/E1]: it comigrates in SDS-PAGE with [E2]non-muscle myosin heavy chain[/E2]; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "non-muscle myosin heavy chain", "entity_1_idx": [[178, 207]], "entity_1_idx_in_text_with_entity_marker": [182, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-muscle myosin heavy chain", "entity_2_idx": [[240, 269]], "entity_2_idx_in_text_with_entity_marker": [253, 282], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p2", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with [E1]non-muscle myosin heavy chain[/E1]; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified [E2]actin[/E2] filaments in the absence of ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "non-muscle myosin heavy chain", "entity_1_idx": [[240, 269]], "entity_1_idx_in_text_with_entity_marker": [244, 273], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[382, 387]], "entity_2_idx_in_text_with_entity_marker": [395, 400], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p3", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by [E1]myosin heavy chain[/E1] antibodies and was found to possess other characteristics of conventional [E2]non-muscle myosin heavy chain[/E2]: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[85, 103]], "entity_1_idx_in_text_with_entity_marker": [89, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "non-muscle myosin heavy chain", "entity_2_idx": [[178, 207]], "entity_2_idx_in_text_with_entity_marker": [191, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p4", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by [E1]myosin heavy chain[/E1] antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified [E2]actin[/E2] filaments in the absence of ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[85, 103]], "entity_1_idx_in_text_with_entity_marker": [89, 107], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[382, 387]], "entity_2_idx_in_text_with_entity_marker": [395, 400], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d244.s0_BioInfer.d244.s0.p5", "text": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.", "text_with_entity_marker": "Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional [E1]non-muscle myosin heavy chain[/E1]: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified [E2]actin[/E2] filaments in the absence of ATP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "non-muscle myosin heavy chain", "entity_1_idx": [[178, 207]], "entity_1_idx_in_text_with_entity_marker": [182, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[382, 387]], "entity_2_idx_in_text_with_entity_marker": [395, 400], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p0", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as [E1]verprolin[/E1]/[E2]cofilin[/E2]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p1", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as [E2]verprolin[/E2]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p2", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as [E2]verprolin[/E2]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p3", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as [E1]verprolin[/E1]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p4", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as [E1]verprolin[/E1]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p5", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as [E1]verprolin[/E1]/cofilin-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p6", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as [E1]verprolin[/E1]/cofilin-like actin-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p7", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as [E2]verprolin[/E2]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "verprolin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p8", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as verprolin/[E2]cofilin[/E2]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p9", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E2]cofilin[/E2]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p0", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of cofilin and [E1]profilin[/E1] from porcine brain on rate of exchange of [E2]actin[/E2]-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p1", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of [E1]cofilin[/E1] and [E2]profilin[/E2] from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[32, 40]], "entity_2_idx_in_text_with_entity_marker": [45, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p2", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of [E1]cofilin[/E1] and profilin from porcine brain on rate of exchange of [E2]actin[/E2]-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d677.s0_BioInfer.d677.s0.p0", "text": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially myosin heavy chain (MHC) and actin.", "text_with_entity_marker": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[134, 137]], "entity_1_idx_in_text_with_entity_marker": [138, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d677.s0_BioInfer.d677.s0.p1", "text": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially myosin heavy chain (MHC) and actin.", "text_with_entity_marker": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[114, 132]], "entity_1_idx_in_text_with_entity_marker": [118, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d677.s0_BioInfer.d677.s0.p2", "text": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially myosin heavy chain (MHC) and actin.", "text_with_entity_marker": "The qualitative changes involve differential expression of multigene families of contractile proteins, especially [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[114, 132]], "entity_1_idx_in_text_with_entity_marker": [118, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[134, 137]], "entity_2_idx_in_text_with_entity_marker": [147, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p0", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and [E1]UL52[/E1]), the origin-binding protein ([E2]UL9[/E2]), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p1", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and [E1]UL52[/E1]), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p2", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, UL8, and [E2]UL52[/E2]), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p3", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and [E1]UL52[/E1]), the origin-binding protein (UL9), and the viral [E2]single-stranded DNA-binding protein[/E2] (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "single-stranded DNA-binding protein", "entity_2_idx": [[213, 248]], "entity_2_idx_in_text_with_entity_marker": [226, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p4", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components ([E1]UL5[/E1], UL8, and [E2]UL52[/E2]), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p5", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, [E1]UL8[/E1], and [E2]UL52[/E2]), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[149, 152]], "entity_1_idx_in_text_with_entity_marker": [153, 156], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p6", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and [E1]UL52[/E1]), the [E2]origin-binding protein[/E2] (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "origin-binding protein", "entity_2_idx": [[169, 191]], "entity_2_idx_in_text_with_entity_marker": [182, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p7", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein ([E1]UL9[/E1]), and the viral single-stranded DNA-binding protein ([E2]ICP8[/E2]) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL9", "entity_1_idx": [[193, 196]], "entity_1_idx_in_text_with_entity_marker": [197, 200], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p8", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, UL8, and UL52), the origin-binding protein ([E2]UL9[/E2]), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL9", "entity_2_idx": [[193, 196]], "entity_2_idx_in_text_with_entity_marker": [206, 209], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p9", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein ([E1]UL9[/E1]), and the viral [E2]single-stranded DNA-binding protein[/E2] (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL9", "entity_1_idx": [[193, 196]], "entity_1_idx_in_text_with_entity_marker": [197, 200], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "single-stranded DNA-binding protein", "entity_2_idx": [[213, 248]], "entity_2_idx_in_text_with_entity_marker": [226, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s0_BioInfer.d355.s0.p0", "text": "Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.", "text_with_entity_marker": "Insulin-like growth factor I stimulates [E1]cardiac myosin heavy chain[/E1] and [E2]actin[/E2] synthesis in the awake rat.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[40, 66]], "entity_1_idx_in_text_with_entity_marker": [44, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s0_BioInfer.d355.s0.p1", "text": "Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.", "text_with_entity_marker": "[E1]Insulin-like growth factor I[/E1] stimulates [E2]cardiac myosin heavy chain[/E2] and actin synthesis in the awake rat.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Insulin-like growth factor I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cardiac myosin heavy chain", "entity_2_idx": [[40, 66]], "entity_2_idx_in_text_with_entity_marker": [53, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s0_BioInfer.d355.s0.p2", "text": "Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.", "text_with_entity_marker": "[E1]Insulin-like growth factor I[/E1] stimulates cardiac myosin heavy chain and [E2]actin[/E2] synthesis in the awake rat.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Insulin-like growth factor I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p0", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E1]myosin heavy chain[/E1] and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p1", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p2", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E1]actin[/E1] during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[198, 203]], "entity_1_idx_in_text_with_entity_marker": [202, 207], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p3", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and [E2]actin[/E2] during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[198, 203]], "entity_2_idx_in_text_with_entity_marker": [211, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p4", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E2]myosin heavy chain[/E2] and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p5", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E1]myosin heavy chain[/E1] and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p6", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into [E2]myosin heavy chain[/E2] and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p7", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p8", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of [E1]insulin-like growth factor I[/E1] ([E2]IGF-I[/E2]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin-like growth factor I", "entity_1_idx": [[27, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s1_BioInfer.d355.s1.p9", "text": "To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.", "text_with_entity_marker": "To determine the effect of insulin-like growth factor I ([E1]IGF-I[/E1]) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or [E2]IGF-I[/E2] (1 microgram. kg-1. min-1) in awake rats.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IGF-I", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IGF-I", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p40", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases-8[/E1] and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases-8", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p41", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases-8[/E1] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases-8", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p42", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E1-E2]TRAIL receptors[/E1] 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL receptors", "entity_1_idx": [[166, 181], [188, 189]], "entity_1_idx_in_text_with_entity_marker": [173, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors[/E1] 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [173, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p43", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E1]TRAIL receptors[/E1] 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL receptors", "entity_1_idx": [[166, 181], [188, 189]], "entity_1_idx_in_text_with_entity_marker": [170, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p44", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E1]TRAIL receptors 1[/E1] and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL receptors 1", "entity_1_idx": [[166, 183]], "entity_1_idx_in_text_with_entity_marker": [170, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d714.s0_BioInfer.d714.s0.p0", "text": "These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.", "text_with_entity_marker": "These results suggest that the heptapeptide sequence is specific for the interaction with [E1]actin[/E1] and, therefore, may constitute part of the actin-binding domain of [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[163, 170]], "entity_2_idx_in_text_with_entity_marker": [176, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d714.s0_BioInfer.d714.s0.p1", "text": "These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.", "text_with_entity_marker": "These results suggest that the heptapeptide sequence is specific for the interaction with [E1]actin[/E1] and, therefore, may constitute part of the [E2]actin[/E2]-binding domain of cofilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d714.s0_BioInfer.d714.s0.p2", "text": "These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.", "text_with_entity_marker": "These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the [E1]actin[/E1]-binding domain of [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[139, 144]], "entity_1_idx_in_text_with_entity_marker": [143, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[163, 170]], "entity_2_idx_in_text_with_entity_marker": [176, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p7", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and [E1]plakoglobin[/E1] bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[54, 65]], "entity_1_idx_in_text_with_entity_marker": [58, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p8", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p9", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, [E1]beta-catenin[/E1] competed with the binding of [E2]plakoglobin[/E2] to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[108, 120]], "entity_1_idx_in_text_with_entity_marker": [112, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[150, 161]], "entity_2_idx_in_text_with_entity_marker": [163, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p10", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and [E1]plakoglobin[/E1] bind to the same region of alpha-catenin, [E2]beta-catenin[/E2] competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[54, 65]], "entity_1_idx_in_text_with_entity_marker": [58, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[108, 120]], "entity_2_idx_in_text_with_entity_marker": [121, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p11", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and plakoglobin bind to the same region of alpha-catenin, [E2]beta-catenin[/E2] competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[108, 120]], "entity_2_idx_in_text_with_entity_marker": [121, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p12", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and [E1]plakoglobin[/E1] bind to the same region of alpha-catenin, beta-catenin competed with the binding of [E2]plakoglobin[/E2] to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[54, 65]], "entity_1_idx_in_text_with_entity_marker": [58, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[150, 161]], "entity_2_idx_in_text_with_entity_marker": [163, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p13", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of [E2]plakoglobin[/E2] to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[150, 161]], "entity_2_idx_in_text_with_entity_marker": [163, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p14", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[54, 65]], "entity_2_idx_in_text_with_entity_marker": [67, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s2_BioInfer.d61.s2.p0", "text": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[152, 164]], "entity_1_idx_in_text_with_entity_marker": [156, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[169, 180]], "entity_2_idx_in_text_with_entity_marker": [182, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s2_BioInfer.d61.s2.p1", "text": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in [E1]alpha-catenin[/E1] required for molecular interaction with [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[98, 111]], "entity_1_idx_in_text_with_entity_marker": [102, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[152, 164]], "entity_2_idx_in_text_with_entity_marker": [165, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s2_BioInfer.d61.s2.p2", "text": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in [E1]alpha-catenin[/E1] required for molecular interaction with beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[98, 111]], "entity_1_idx_in_text_with_entity_marker": [102, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[169, 180]], "entity_2_idx_in_text_with_entity_marker": [182, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s3_BioInfer.d61.s3.p0", "text": "When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.", "text_with_entity_marker": "When transfected into L cells expressing [E1]E-cadherin[/E1], the amino-terminal region of [E2]alpha-catenin[/E2] (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[41, 51]], "entity_1_idx_in_text_with_entity_marker": [45, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s3_BioInfer.d61.s3.p1", "text": "When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.", "text_with_entity_marker": "When transfected into L cells expressing E-cadherin, the amino-terminal region of [E1]alpha-catenin[/E1] (from residue 1 to 226) formed complexes with [E2]beta-catenin[/E2] supporting the in vitro binding experiment results.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[142, 154]], "entity_2_idx_in_text_with_entity_marker": [155, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s3_BioInfer.d61.s3.p2", "text": "When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.", "text_with_entity_marker": "When transfected into L cells expressing [E1]E-cadherin[/E1], the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with [E2]beta-catenin[/E2] supporting the in vitro binding experiment results.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[41, 51]], "entity_1_idx_in_text_with_entity_marker": [45, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[142, 154]], "entity_2_idx_in_text_with_entity_marker": [155, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p0", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net [E1]actin[/E1] protein synthesis and a 3.3-fold increase in net [E2]myosin heavy chain[/E2] synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[196, 214]], "entity_2_idx_in_text_with_entity_marker": [209, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p1", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the [E1]TNF-alpha[/E1]-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net [E2]myosin heavy chain[/E2] synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-alpha", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[196, 214]], "entity_2_idx_in_text_with_entity_marker": [209, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p2", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with [E1]TNF-alpha[/E1] led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net [E2]myosin heavy chain[/E2] synthesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[97, 106]], "entity_1_idx_in_text_with_entity_marker": [101, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[196, 214]], "entity_2_idx_in_text_with_entity_marker": [209, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p3", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the [E1]TNF-alpha[/E1]-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net [E2]actin[/E2] protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-alpha", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p4", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with [E1]TNF-alpha[/E1] led to a 2.4-fold increase in net [E2]actin[/E2] protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[97, 106]], "entity_1_idx_in_text_with_entity_marker": [101, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d312.s0_BioInfer.d312.s0.p5", "text": "In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "text_with_entity_marker": "In addition to the [E1]TNF-alpha[/E1]-induced increase in the general protein synthesis, stimulation with [E2]TNF-alpha[/E2] led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-alpha", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF-alpha", "entity_2_idx": [[97, 106]], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p10", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p11", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E1]actin[/E1]-activated ATPase than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p12", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p13", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p14", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p15", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, [E2]alpha Myosin[/E2] exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha Myosin", "entity_2_idx": [[82, 94]], "entity_2_idx_in_text_with_entity_marker": [95, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p16", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher [E2]actin[/E2]-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p17", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, [E2]alpha Myosin[/E2] exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha Myosin", "entity_2_idx": [[82, 94]], "entity_2_idx_in_text_with_entity_marker": [95, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p18", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing [E1]alpha myosin[/E1] exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha myosin", "entity_1_idx": [[179, 191]], "entity_1_idx_in_text_with_entity_marker": [183, 195], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p19", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p20", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E1]actin[/E1]-activated ATPase than does beta myosin, and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p21", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p22", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p23", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E1]actin[/E1]-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p24", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p25", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E2]actin[/E2]-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p26", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1-E2]cardiac myosin heavy chain[/E1-E2] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [15, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cardiac myosin heavy chain", "entity_2_idx": [[8, 34], [45, 50]], "entity_2_idx_in_text_with_entity_marker": [15, 41], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p27", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E2]actin[/E2]-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d641.s0_BioInfer.d641.s0.p0", "text": "The majority of the aromatic residues in profilin are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with actin.", "text_with_entity_marker": "The majority of the aromatic residues in [E1]profilin[/E1] are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p0", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], actin, tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p1", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], [E2]calbindin[/E2], actin, tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calbindin", "entity_2_idx": [[38, 47]], "entity_2_idx_in_text_with_entity_marker": [51, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p2", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], [E2]actin[/E2], tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p3", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], actin, [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p4", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, actin, tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p5", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, [E1]actin[/E1], tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p6", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, actin, [E1]tubulin[/E1], and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tubulin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p7", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, [E2]actin[/E2], tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p8", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, actin, [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p9", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, [E1]actin[/E1], [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p10", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p11", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p12", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p13", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], [E2]TRADD[/E2], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p14", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p15", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p16", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p17", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, [E1]RIP[/E1], and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p18", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p19", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p40", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p41", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p42", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p43", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p44", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E1]FADD[/E1] and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[287, 291]], "entity_1_idx_in_text_with_entity_marker": [291, 295], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p0", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p1", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p2", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p3", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p4", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p45", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p46", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p47", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p48", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p49", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p50", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p51", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p52", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], [E2]TNFR-1[/E2], TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR-1", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p53", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], [E2]Fas ligand[/E2], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas ligand", "entity_2_idx": [[140, 150]], "entity_2_idx_in_text_with_entity_marker": [153, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p54", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, [E2]TNFR-1[/E2], TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR-1", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p0", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that [E1]E-APC[/E1] also requires [E2]actin[/E2] filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-APC", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p1", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of [E1]profilin[/E1] mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires [E2]actin[/E2] filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p2", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of profilin mutants, whose [E1]actin[/E1] cytoskeleton is disrupted, we found that E-APC also requires [E2]actin[/E2] filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p3", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of [E1]profilin[/E1] mutants, whose actin cytoskeleton is disrupted, we found that [E2]E-APC[/E2] also requires actin filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-APC", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p4", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of profilin mutants, whose [E1]actin[/E1] cytoskeleton is disrupted, we found that [E2]E-APC[/E2] also requires actin filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-APC", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p5", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of [E1]profilin[/E1] mutants, whose [E2]actin[/E2] cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p80", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E1]H3[/E1]; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[383, 385]], "entity_1_idx_in_text_with_entity_marker": [387, 389], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p81", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p82", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p83", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p84", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p85", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p86", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p87", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p88", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p89", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d291.s0_BioInfer.d291.s0.p0", "text": "Immunohistochemical identification and localization of actin and fimbrin in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.", "text_with_entity_marker": "Immunohistochemical identification and localization of [E1]actin[/E1] and [E2]fimbrin[/E2] in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[65, 72]], "entity_2_idx_in_text_with_entity_marker": [78, 85], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p0", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins ([E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p1", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins (E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2]) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p2", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins (E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p3", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins ([E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]gamma-catenin[/E2]) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p4", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins ([E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s0_BioInfer.d280.s0.p5", "text": "However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "text_with_entity_marker": "However, when all of the four proteins (E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2]) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s1_BioInfer.d280.s1.p0", "text": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.", "text_with_entity_marker": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for [E1]beta-catenin[/E1], and in 50 (55.6 per cent) for [E2]gamma-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[132, 144]], "entity_1_idx_in_text_with_entity_marker": [136, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s1_BioInfer.d280.s1.p1", "text": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.", "text_with_entity_marker": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for [E1]alpha-catenin[/E1], in 50 (55.6 per cent) for [E2]beta-catenin[/E2], and in 50 (55.6 per cent) for gamma-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[91, 104]], "entity_1_idx_in_text_with_entity_marker": [95, 108], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[132, 144]], "entity_2_idx_in_text_with_entity_marker": [145, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d280.s1_BioInfer.d280.s1.p2", "text": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.", "text_with_entity_marker": "Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for [E1]alpha-catenin[/E1], in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for [E2]gamma-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[91, 104]], "entity_1_idx_in_text_with_entity_marker": [95, 108], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p0", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], UL8, [E2]UL9[/E2], and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p1", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], [E2]UL8[/E2], UL9, and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[71, 74]], "entity_2_idx_in_text_with_entity_marker": [84, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p2", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed [E1]UL5[/E1], UL8, UL9, and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p3", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, [E1]UL8[/E1], [E2]UL9[/E2], and UL52 in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p4", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, UL8, [E1]UL9[/E1], and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s0_BioInfer.d769.s0.p5", "text": "To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.", "text_with_entity_marker": "To improve our ability to study these proteins, we have expressed UL5, [E1]UL8[/E1], UL9, and [E2]UL52[/E2] in insect cells by using the baculovirus expression system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p0", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, [E1]UL8[/E1], UL9, and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p1", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, UL8, [E1]UL9[/E1], and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL9", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p2", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], UL8, UL9, and [E2]UL52[/E2]) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p3", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins (UL5, [E1]UL8[/E1], [E2]UL9[/E2], and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[71, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p4", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], [E2]UL8[/E2], UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[71, 74]], "entity_2_idx_in_text_with_entity_marker": [84, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d769.s1_BioInfer.d769.s1.p5", "text": "Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.", "text_with_entity_marker": "Various immunological assays suggest that four of these proteins ([E1]UL5[/E1], UL8, [E2]UL9[/E2], and UL52) are made in infected cells in very low abundance relative to the other three.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p40", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E2]SRV2[/E2], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SRV2", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p41", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p42", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, [E2]NAB1[/E2], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NAB1", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p43", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], DBR1, [E2]CDC55[/E2], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CDC55", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p44", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], [E2]NAB1[/E2], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NAB1", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p45", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], DBR1, CDC55, SRV2, [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p46", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], [E2]DBR1[/E2], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DBR1", "entity_2_idx": [[237, 241]], "entity_2_idx_in_text_with_entity_marker": [250, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p47", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], DBR1, CDC55, SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p48", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p49", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, [E1]NAB1[/E1], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NAB1", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p110", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E1]DFG9[/E1], DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG9", "entity_1_idx": [[280, 284]], "entity_1_idx_in_text_with_entity_marker": [284, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p111", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p112", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p113", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E1]DFG5[/E1], DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG5", "entity_1_idx": [[274, 278]], "entity_1_idx_in_text_with_entity_marker": [278, 282], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p114", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p115", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p116", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E1]DFG5[/E1], [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG5", "entity_1_idx": [[274, 278]], "entity_1_idx_in_text_with_entity_marker": [278, 282], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p117", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p118", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p119", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s3_BioInfer.d35.s3.p1", "text": "Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.", "text_with_entity_marker": "Here, we report that [E1]Aip1p[/E1] also interacts with the ubiquitous [E2]actin depolymerizing factor[/E2] cofilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[62, 89]], "entity_2_idx_in_text_with_entity_marker": [75, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s3_BioInfer.d35.s3.p2", "text": "Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.", "text_with_entity_marker": "Here, we report that [E1]Aip1p[/E1] also interacts with the ubiquitous actin depolymerizing factor [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p0", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of [E1]cofilin[/E1] and restricts cofilin localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[106, 113]], "entity_1_idx_in_text_with_entity_marker": [110, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p1", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a cofilin-associated protein that enhances the filament disassembly activity of [E2]cofilin[/E2] and restricts cofilin localization to cortical actin patches.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[106, 113]], "entity_2_idx_in_text_with_entity_marker": [119, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p2", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of [E1]cofilin[/E1] and restricts [E2]cofilin[/E2] localization to cortical actin patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[106, 113]], "entity_1_idx_in_text_with_entity_marker": [110, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p3", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a [E1]cofilin[/E1]-associated protein that enhances the filament disassembly activity of [E2]cofilin[/E2] and restricts cofilin localization to cortical actin patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[28, 35]], "entity_1_idx_in_text_with_entity_marker": [32, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[106, 113]], "entity_2_idx_in_text_with_entity_marker": [119, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p4", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p5", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts [E1]cofilin[/E1] localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[128, 135]], "entity_1_idx_in_text_with_entity_marker": [132, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p6", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a [E1]cofilin[/E1]-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[28, 35]], "entity_1_idx_in_text_with_entity_marker": [32, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p7", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts [E2]cofilin[/E2] localization to cortical actin patches.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d117.s0_BioInfer.d117.s0.p0", "text": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.", "text_with_entity_marker": "By 1 h the cells were well spread with straight [E1]actin[/E1] bundles many of which ended at more central sites terminating on patches containing vinculin and [E2]talin[/E2]; thus the cells assemble typical stress fibers but do not appear to polarize.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d117.s0_BioInfer.d117.s0.p1", "text": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.", "text_with_entity_marker": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing [E1]vinculin[/E1] and [E2]talin[/E2]; thus the cells assemble typical stress fibers but do not appear to polarize.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d117.s0_BioInfer.d117.s0.p2", "text": "By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.", "text_with_entity_marker": "By 1 h the cells were well spread with straight [E1]actin[/E1] bundles many of which ended at more central sites terminating on patches containing [E2]vinculin[/E2] and talin; thus the cells assemble typical stress fibers but do not appear to polarize.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[138, 146]], "entity_2_idx_in_text_with_entity_marker": [151, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p0", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p1", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p2", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and Tcf-4, which bind to the [E2]armadillo[/E2] repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "armadillo", "entity_2_idx": [[93, 102]], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p3", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and [E2]Tcf-4[/E2], which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tcf-4", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p4", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of [E2]alpha-catenin[/E2], although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[155, 168]], "entity_2_idx_in_text_with_entity_marker": [168, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p5", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of [E1]N-cadherin[/E1], [E2]APC[/E2], and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p6", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, [E1]APC[/E1], and Tcf-4, which bind to the armadillo repeats of [E2]beta-catenin[/E2], but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[114, 126]], "entity_2_idx_in_text_with_entity_marker": [127, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p7", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although [E1]alpha-catenin[/E1] expression did prevent accumulation of [E2]beta-catenin[/E2] in the nucleus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[179, 192]], "entity_1_idx_in_text_with_entity_marker": [183, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[232, 244]], "entity_2_idx_in_text_with_entity_marker": [245, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p8", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the [E1]armadillo[/E1] repeats of beta-catenin, but not by coexpression of alpha-catenin, although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "armadillo", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d524.s0_BioInfer.d524.s0.p9", "text": "Rod formation was prevented by coexpression of N-cadherin, APC, and Tcf-4, which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although alpha-catenin expression did prevent accumulation of beta-catenin in the nucleus.", "text_with_entity_marker": "Rod formation was prevented by coexpression of N-cadherin, APC, and [E1]Tcf-4[/E1], which bind to the armadillo repeats of beta-catenin, but not by coexpression of alpha-catenin, although [E2]alpha-catenin[/E2] expression did prevent accumulation of beta-catenin in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Tcf-4", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[179, 192]], "entity_2_idx_in_text_with_entity_marker": [192, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p4", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp[/E1]2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for [E2]actin[/E2] monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[68, 71], [73, 74]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[229, 234]], "entity_2_idx_in_text_with_entity_marker": [242, 247], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p5", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp2[/E1]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E2]profilin[/E2] for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p6", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E2]profilin[/E2] for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p7", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E1]profilin[/E1] for barbed ends of [E2]actin[/E2] filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p8", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp[/E1]2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of [E2]profilin[/E2] for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[68, 71], [73, 74]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p9", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds [E2]Arp2[/E2]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p10", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1]Arp2[/E1]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of [E2]actin[/E2] filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p11", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled profilin binds [E1-E2]Arp[/E1]2[/E2]/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[68, 71], [73, 74]], "entity_1_idx_in_text_with_entity_marker": [75, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [75, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p12", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of [E2]actin[/E2] filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d77.s1_BioInfer.d77.s1.p13", "text": "By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "text_with_entity_marker": "By analytical ultracentrifugation, rhodamine-labeled [E1]profilin[/E1] binds [E2]Arp[/E2]2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[68, 71], [73, 74]], "entity_2_idx_in_text_with_entity_marker": [81, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p0", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of [E1]class II myosins[/E1], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "class II myosins", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p1", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of [E1]class II myosins[/E1], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated [E2]actin[/E2]-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "class II myosins", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[266, 271]], "entity_2_idx_in_text_with_entity_marker": [279, 284], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p2", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of [E1]class II myosins[/E1], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent [E2]MgATPase[/E2] activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "class II myosins", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MgATPase", "entity_2_idx": [[282, 290]], "entity_2_idx_in_text_with_entity_marker": [295, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p3", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of [E2]class II myosins[/E2], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "class II myosins", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p4", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated [E1]actin[/E1]-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[266, 271]], "entity_1_idx_in_text_with_entity_marker": [270, 275], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p5", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent [E1]MgATPase[/E1] activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MgATPase", "entity_1_idx": [[282, 290]], "entity_1_idx_in_text_with_entity_marker": [286, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p6", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p7", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated [E1]actin[/E1]-dependent [E2]MgATPase[/E2] activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[266, 271]], "entity_1_idx_in_text_with_entity_marker": [270, 275], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MgATPase", "entity_2_idx": [[282, 290]], "entity_2_idx_in_text_with_entity_marker": [295, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p8", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated [E2]actin[/E2]-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[266, 271]], "entity_2_idx_in_text_with_entity_marker": [279, 284], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p9", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent [E2]MgATPase[/E2] activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MgATPase", "entity_2_idx": [[282, 290]], "entity_2_idx_in_text_with_entity_marker": [295, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d408.s0_BioInfer.d408.s0.p0", "text": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.", "text_with_entity_marker": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of [E1]profilin[/E1], which in turn can supply [E2]actin[/E2] monomers to growing filament ends.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d408.s0_BioInfer.d408.s0.p1", "text": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.", "text_with_entity_marker": "Localization of [E1]VASP[/E1] to the leading edge of a migrating cell can lead to local accumulation of [E2]profilin[/E2], which in turn can supply actin monomers to growing filament ends.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VASP", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d408.s0_BioInfer.d408.s0.p2", "text": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.", "text_with_entity_marker": "Localization of [E1]VASP[/E1] to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply [E2]actin[/E2] monomers to growing filament ends.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p8", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of [E1]alpha-catenin[/E1], beta-catenin, [E2]gamma-catenin[/E2] and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[115, 128]], "entity_1_idx_in_text_with_entity_marker": [119, 132], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[144, 157]], "entity_2_idx_in_text_with_entity_marker": [157, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p9", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, [E1]gamma-catenin[/E1] and [E2]E-cadherin[/E2] in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[144, 157]], "entity_1_idx_in_text_with_entity_marker": [148, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p0", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: E-cadherin, [E1]alpha-catenin[/E1], beta-catenin and [E2]gamma-catenin[/E2] were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[21, 34]], "entity_1_idx_in_text_with_entity_marker": [25, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[53, 66]], "entity_2_idx_in_text_with_entity_marker": [66, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p1", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[9, 19]], "entity_1_idx_in_text_with_entity_marker": [13, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[21, 34]], "entity_2_idx_in_text_with_entity_marker": [34, 47], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p2", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[21, 34]], "entity_1_idx_in_text_with_entity_marker": [25, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[36, 48]], "entity_2_idx_in_text_with_entity_marker": [49, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p3", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: [E1]E-cadherin[/E1], alpha-catenin, beta-catenin and [E2]gamma-catenin[/E2] were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[9, 19]], "entity_1_idx_in_text_with_entity_marker": [13, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[53, 66]], "entity_2_idx_in_text_with_entity_marker": [66, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p4", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: E-cadherin, alpha-catenin, [E1]beta-catenin[/E1] and [E2]gamma-catenin[/E2] were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[36, 48]], "entity_1_idx_in_text_with_entity_marker": [40, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[53, 66]], "entity_2_idx_in_text_with_entity_marker": [66, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s3_BioInfer.d33.s3.p5", "text": "RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "text_with_entity_marker": "RESULTS: [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2] and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[9, 19]], "entity_1_idx_in_text_with_entity_marker": [13, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[36, 48]], "entity_2_idx_in_text_with_entity_marker": [49, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s0_BioInfer.d161.s0.p0", "text": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.", "text_with_entity_marker": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, [E1]thymosin beta(4)[/E1], and [E2]actin[/E2] form a ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "thymosin beta(4)", "entity_1_idx": [[139, 155]], "entity_1_idx_in_text_with_entity_marker": [143, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s0_BioInfer.d161.s0.p1", "text": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.", "text_with_entity_marker": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that [E1]profilin[/E1], [E2]thymosin beta(4)[/E2], and actin form a ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[129, 137]], "entity_1_idx_in_text_with_entity_marker": [133, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta(4)", "entity_2_idx": [[139, 155]], "entity_2_idx_in_text_with_entity_marker": [152, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s0_BioInfer.d161.s0.p2", "text": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.", "text_with_entity_marker": "Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that [E1]profilin[/E1], thymosin beta(4), and [E2]actin[/E2] form a ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[129, 137]], "entity_1_idx_in_text_with_entity_marker": [133, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p0", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why [E1]thymosin beta(4)[/E1] and profilin can bind simultaneously to [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "thymosin beta(4)", "entity_1_idx": [[204, 220]], "entity_1_idx_in_text_with_entity_marker": [208, 224], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[261, 266]], "entity_2_idx_in_text_with_entity_marker": [274, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p1", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between [E1]actin[/E1] and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[261, 266]], "entity_2_idx_in_text_with_entity_marker": [274, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p2", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of [E1]thymosin beta(4)[/E1] (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[66, 82]], "entity_1_idx_in_text_with_entity_marker": [70, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[261, 266]], "entity_2_idx_in_text_with_entity_marker": [274, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p3", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and [E1]thymosin beta(4)[/E1], and explain why thymosin beta(4) and profilin can bind simultaneously to [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[170, 186]], "entity_1_idx_in_text_with_entity_marker": [174, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[261, 266]], "entity_2_idx_in_text_with_entity_marker": [274, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p4", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and [E1]profilin[/E1] can bind simultaneously to [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[225, 233]], "entity_1_idx_in_text_with_entity_marker": [229, 237], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[261, 266]], "entity_2_idx_in_text_with_entity_marker": [274, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p5", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between [E1]actin[/E1] and thymosin beta(4), and explain why [E2]thymosin beta(4)[/E2] and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta(4)", "entity_2_idx": [[204, 220]], "entity_2_idx_in_text_with_entity_marker": [217, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p6", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of [E1]thymosin beta(4)[/E1] (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why [E2]thymosin beta(4)[/E2] and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[66, 82]], "entity_1_idx_in_text_with_entity_marker": [70, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin beta(4)", "entity_2_idx": [[204, 220]], "entity_2_idx_in_text_with_entity_marker": [217, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p7", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and [E1]thymosin beta(4)[/E1], and explain why [E2]thymosin beta(4)[/E2] and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[170, 186]], "entity_1_idx_in_text_with_entity_marker": [174, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta(4)", "entity_2_idx": [[204, 220]], "entity_2_idx_in_text_with_entity_marker": [217, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p8", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why [E1]thymosin beta(4)[/E1] and [E2]profilin[/E2] can bind simultaneously to actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "thymosin beta(4)", "entity_1_idx": [[204, 220]], "entity_1_idx_in_text_with_entity_marker": [208, 224], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p9", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of [E1]thymosin beta(4)[/E1] (residues 6-22) confirm the presence of an extensive binding surface between [E2]actin[/E2] and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[66, 82]], "entity_1_idx_in_text_with_entity_marker": [70, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p10", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between [E1]actin[/E1] and [E2]thymosin beta(4)[/E2], and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta(4)", "entity_2_idx": [[170, 186]], "entity_2_idx_in_text_with_entity_marker": [183, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p11", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between [E1]actin[/E1] and thymosin beta(4), and explain why thymosin beta(4) and [E2]profilin[/E2] can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p12", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of [E1]thymosin beta(4)[/E1] (residues 6-22) confirm the presence of an extensive binding surface between actin and [E2]thymosin beta(4)[/E2], and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[66, 82]], "entity_1_idx_in_text_with_entity_marker": [70, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin beta(4)", "entity_2_idx": [[170, 186]], "entity_2_idx_in_text_with_entity_marker": [183, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p13", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of [E1]thymosin beta(4)[/E1] (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and [E2]profilin[/E2] can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[66, 82]], "entity_1_idx_in_text_with_entity_marker": [70, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d161.s1_BioInfer.d161.s1.p14", "text": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.", "text_with_entity_marker": "Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and [E1]thymosin beta(4)[/E1], and explain why thymosin beta(4) and [E2]profilin[/E2] can bind simultaneously to actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta(4)", "entity_1_idx": [[170, 186]], "entity_1_idx_in_text_with_entity_marker": [174, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p0", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p1", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p2", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and [E1]matrix[/E1] (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[119, 125], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [123, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p3", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p4", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p5", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E1]H[/E1], F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[153, 154], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [157, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p6", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E1]NP[/E1] and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[159, 161], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [163, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p7", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p8", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E1]F[/E1], [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[156, 157], [168, 176]], "entity_1_idx_in_text_with_entity_marker": [160, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p9", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p10", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and [E2]18S rRNA[/E2], actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S rRNA", "entity_2_idx": [[48, 56]], "entity_2_idx_in_text_with_entity_marker": [61, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p11", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p12", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p13", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, [E2]actin I[/E2], profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin I", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p14", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p15", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p16", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p17", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p18", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for [E1]5S[/E1], 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "5S", "entity_1_idx": [[35, 37], [52, 56]], "entity_1_idx_in_text_with_entity_marker": [39, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p19", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and [E1]18S rRNA[/E1], actin I, [E2]profilins Ia[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S rRNA", "entity_1_idx": [[48, 56]], "entity_1_idx_in_text_with_entity_marker": [52, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins Ia", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p0", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-[E1]TGF-beta1[/E1] showed that beta-catenin, [E2]plakoglobin[/E2], alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TGF-beta1", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p1", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-[E1]TGF-beta1[/E1] showed that [E2]beta-catenin[/E2], plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TGF-beta1", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[89, 101]], "entity_2_idx_in_text_with_entity_marker": [102, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p2", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-[E1]TGF-beta1[/E1] showed that beta-catenin, plakoglobin, alpha-catenin, and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TGF-beta1", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p3", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-[E1]TGF-beta1[/E1] showed that beta-catenin, plakoglobin, [E2]alpha-catenin[/E2], and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TGF-beta1", "entity_1_idx": [[67, 76]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p4", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p5", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, [E1]plakoglobin[/E1], alpha-catenin, and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[103, 114]], "entity_1_idx_in_text_with_entity_marker": [107, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p6", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, [E1]plakoglobin[/E1], [E2]alpha-catenin[/E2], and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[103, 114]], "entity_1_idx_in_text_with_entity_marker": [107, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p7", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], plakoglobin, alpha-catenin, and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p8", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], plakoglobin, [E2]alpha-catenin[/E2], and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p9", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, [E1]alpha-catenin[/E1], and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p10", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, [E1]TRADD[/E1], and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p11", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, [E1]FAF[/E1], [E2]TRADD[/E2], and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FAF", "entity_1_idx": [[84, 87]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p12", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, FADD, DR3, FAF, [E2]TRADD[/E2], and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p13", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, [E1]DR3[/E1], FAF, [E2]TRADD[/E2], and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p14", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, [E1]Fas[/E1], FADD, DR3, FAF, [E2]TRADD[/E2], and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[68, 71]], "entity_1_idx_in_text_with_entity_marker": [72, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p15", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1([E1]p55[/E1]), as well as that of FLICE, Fas, FADD, DR3, FAF, [E2]TRADD[/E2], and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p16", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, [E1]TRADD[/E1], and [E2]RIP[/E2] was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p17", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, [E1]FADD[/E1], DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to [E2]TNFalpha[/E2]-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFalpha", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p18", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, [E1]FADD[/E1], DR3, [E2]FAF[/E2], TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FAF", "entity_2_idx": [[84, 87]], "entity_2_idx_in_text_with_entity_marker": [97, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d772.s0_BioInfer.d772.s0.p19", "text": "Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "text_with_entity_marker": "Transcriptional expression of [E1]TNFR1[/E1](p55), as well as that of FLICE, Fas, [E2]FADD[/E2], DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p0", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the [E1]vitamin D-binding protein[/E1] and profilin interactions with [E2]actin[/E2] are similar.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vitamin D-binding protein", "entity_1_idx": [[27, 52]], "entity_1_idx_in_text_with_entity_marker": [31, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p1", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the vitamin D-binding protein and [E1]profilin[/E1] interactions with [E2]actin[/E2] are similar.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[57, 65]], "entity_1_idx_in_text_with_entity_marker": [61, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p2", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the [E1]vitamin D-binding protein[/E1] and [E2]profilin[/E2] interactions with actin are similar.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vitamin D-binding protein", "entity_1_idx": [[27, 52]], "entity_1_idx_in_text_with_entity_marker": [31, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p0", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "Villin and [E1]fimbrin[/E1] are two actin-binding proteins that bundle [E2]actin[/E2] filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[11, 18]], "entity_1_idx_in_text_with_entity_marker": [15, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p1", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "[E1]Villin[/E1] and fimbrin are two actin-binding proteins that bundle [E2]actin[/E2] filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Villin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p2", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "Villin and fimbrin are two [E1]actin-binding proteins[/E1] that bundle [E2]actin[/E2] filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[27, 49]], "entity_1_idx_in_text_with_entity_marker": [31, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p3", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "[E1]Villin[/E1] and [E2]fimbrin[/E2] are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Villin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[11, 18]], "entity_2_idx_in_text_with_entity_marker": [24, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p4", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "Villin and [E1]fimbrin[/E1] are two [E2]actin-binding proteins[/E2] that bundle actin filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[11, 18]], "entity_1_idx_in_text_with_entity_marker": [15, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[27, 49]], "entity_2_idx_in_text_with_entity_marker": [40, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p5", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "[E1]Villin[/E1] and fimbrin are two [E2]actin-binding proteins[/E2] that bundle actin filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Villin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[27, 49]], "entity_2_idx_in_text_with_entity_marker": [40, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p0", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, actin was found in association with [E1]fimbrin[/E1] in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in [E2]actin[/E2], did not reveal fimbrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p1", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, [E1]actin[/E1] was found in association with [E2]fimbrin[/E2] in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p2", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, actin was found in association with [E1]fimbrin[/E1] in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal [E2]fimbrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[161, 168]], "entity_2_idx_in_text_with_entity_marker": [174, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p3", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, [E1]actin[/E1] was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in [E2]actin[/E2], did not reveal fimbrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p4", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in [E1]actin[/E1], did not reveal [E2]fimbrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[139, 144]], "entity_1_idx_in_text_with_entity_marker": [143, 148], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[161, 168]], "entity_2_idx_in_text_with_entity_marker": [174, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p5", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, [E1]actin[/E1] was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal [E2]fimbrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[161, 168]], "entity_2_idx_in_text_with_entity_marker": [174, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p20", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p21", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E2]profilin-I[/E2] has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin-I", "entity_2_idx": [[403, 413]], "entity_2_idx_in_text_with_entity_marker": [416, 426], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p22", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E2]profilins[/E2] rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[139, 148]], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p23", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the [E1]profilins[/E1] fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[40, 49]], "entity_1_idx_in_text_with_entity_marker": [44, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p24", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E2]profilins[/E2] form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[303, 312]], "entity_2_idx_in_text_with_entity_marker": [316, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p25", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native [E2]profilin-I[/E2]; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[464, 474]], "entity_2_idx_in_text_with_entity_marker": [477, 487], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p26", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E2]profilins[/E2] inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[515, 524]], "entity_2_idx_in_text_with_entity_marker": [528, 537], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p27", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba [E2]profilin-I[/E2] has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin-I", "entity_2_idx": [[403, 413]], "entity_2_idx_in_text_with_entity_marker": [416, 426], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p28", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E1]profilins[/E1] rebind quantitatively to poly-L-proline and bind to [E2]actin[/E2] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[139, 148]], "entity_1_idx_in_text_with_entity_marker": [143, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p29", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d758.s0_BioInfer.d758.s0.p0", "text": "TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.", "text_with_entity_marker": "[E1]TNF[/E1] also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[183, 201]], "entity_2_idx_in_text_with_entity_marker": [196, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d758.s0_BioInfer.d758.s0.p1", "text": "TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.", "text_with_entity_marker": "[E1]TNF[/E1] also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as [E2]alpha-skeletal actin[/E2] and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[158, 178]], "entity_2_idx_in_text_with_entity_marker": [171, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d758.s0_BioInfer.d758.s0.p2", "text": "TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.", "text_with_entity_marker": "TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as [E1]alpha-skeletal actin[/E1] and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-skeletal actin", "entity_1_idx": [[158, 178]], "entity_1_idx_in_text_with_entity_marker": [162, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[183, 201]], "entity_2_idx_in_text_with_entity_marker": [196, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p0", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in RVS161 and [E1]RVS167[/E1], the two yeast [E2]amphiphysin[/E2] homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS167", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "amphiphysin", "entity_2_idx": [[46, 57]], "entity_2_idx_in_text_with_entity_marker": [59, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p1", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in RVS161 and [E1]RVS167[/E1], the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized [E2]actin[/E2] cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS167", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p2", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in [E1]RVS161[/E1] and [E2]RVS167[/E2], the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RVS161", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RVS167", "entity_2_idx": [[24, 30]], "entity_2_idx_in_text_with_entity_marker": [37, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p3", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in RVS161 and RVS167, the two yeast [E1]amphiphysin[/E1] homologs, cause very similar growth phenotypes, a depolarized [E2]actin[/E2] cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "amphiphysin", "entity_1_idx": [[46, 57]], "entity_1_idx_in_text_with_entity_marker": [50, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p4", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in [E1]RVS161[/E1] and RVS167, the two yeast [E2]amphiphysin[/E2] homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS161", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "amphiphysin", "entity_2_idx": [[46, 57]], "entity_2_idx_in_text_with_entity_marker": [59, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d444.s0_BioInfer.d444.s0.p5", "text": "Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.", "text_with_entity_marker": "Mutations in [E1]RVS161[/E1] and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized [E2]actin[/E2] cytoskeleton, and a defect in the internalization step of endocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RVS161", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d541.s0_BioInfer.d541.s0.p0", "text": "Since both caldesmon and profilin have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "text_with_entity_marker": "Since both [E1]caldesmon[/E1] and [E2]profilin[/E2] have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caldesmon", "entity_1_idx": [[11, 20]], "entity_1_idx_in_text_with_entity_marker": [15, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d541.s0_BioInfer.d541.s0.p1", "text": "Since both caldesmon and profilin have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "text_with_entity_marker": "Since both caldesmon and [E1]profilin[/E1] have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of [E2]actin[/E2] filaments in living cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d541.s0_BioInfer.d541.s0.p2", "text": "Since both caldesmon and profilin have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "text_with_entity_marker": "Since both [E1]caldesmon[/E1] and profilin have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of [E2]actin[/E2] filaments in living cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caldesmon", "entity_1_idx": [[11, 20]], "entity_1_idx_in_text_with_entity_marker": [15, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d816.s0_BioInfer.d816.s0.p0", "text": "We investigated actin filament turnover rates, length, number, barbed end exposure, and binding of cofilin in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.", "text_with_entity_marker": "We investigated [E1]actin[/E1] filament turnover rates, length, number, barbed end exposure, and binding of [E2]cofilin[/E2] in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[99, 106]], "entity_2_idx_in_text_with_entity_marker": [112, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p0", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to [E1]cadherin[/E1] or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p1", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to [E2]cadherin[/E2] or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[35, 43]], "entity_2_idx_in_text_with_entity_marker": [48, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p2", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to [E1]cadherin[/E1] or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of [E2]beta-catenin[/E2] binding to alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[136, 148]], "entity_2_idx_in_text_with_entity_marker": [149, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p3", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to [E1]cadherin[/E1] or [E2]APC[/E2] protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p4", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p5", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of [E1]beta-catenin[/E1] binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[136, 148]], "entity_1_idx_in_text_with_entity_marker": [140, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p6", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to cadherin or [E1]APC[/E1] protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p7", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of [E2]beta-catenin[/E2] binding to alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[136, 148]], "entity_2_idx_in_text_with_entity_marker": [149, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p8", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in [E1]beta-catenin[/E1] binding to cadherin or [E2]APC[/E2] protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[11, 23]], "entity_1_idx_in_text_with_entity_marker": [15, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d134.s0_BioInfer.d134.s0.p9", "text": "Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.", "text_with_entity_marker": "Changes in beta-catenin binding to cadherin or [E1]APC[/E1] protein, and the ensuing effects on cell morphology and adhesion, are independent of [E2]beta-catenin[/E2] binding to alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[136, 148]], "entity_2_idx_in_text_with_entity_marker": [149, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d718.s0_BioInfer.d718.s0.p0", "text": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.", "text_with_entity_marker": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, [E1]cofilin[/E1], by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[136, 143]], "entity_1_idx_in_text_with_entity_marker": [140, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d718.s0_BioInfer.d718.s0.p1", "text": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.", "text_with_entity_marker": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive [E1]actin[/E1]-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[106, 111]], "entity_1_idx_in_text_with_entity_marker": [110, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d718.s0_BioInfer.d718.s0.p2", "text": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.", "text_with_entity_marker": "These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive [E1]actin[/E1]-depolymerizing protein, [E2]cofilin[/E2], by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[106, 111]], "entity_1_idx_in_text_with_entity_marker": [110, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[136, 143]], "entity_2_idx_in_text_with_entity_marker": [149, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d255.s0_BioInfer.d255.s0.p0", "text": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.", "text_with_entity_marker": "[E1]alpha-SNAP[/E1] binds to predicted alpha-helical coiled-coil regions of [E2]syntaxin[/E2] and SNAP-25, shown previously to be engaged in their direct interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-SNAP", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d255.s0_BioInfer.d255.s0.p1", "text": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.", "text_with_entity_marker": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of [E1]syntaxin[/E1] and [E2]SNAP-25[/E2], shown previously to be engaged in their direct interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAP-25", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d255.s0_BioInfer.d255.s0.p2", "text": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.", "text_with_entity_marker": "[E1]alpha-SNAP[/E1] binds to predicted alpha-helical coiled-coil regions of syntaxin and [E2]SNAP-25[/E2], shown previously to be engaged in their direct interaction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-SNAP", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAP-25", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p20", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to [E1]actin[/E1]-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[186, 191]], "entity_1_idx_in_text_with_entity_marker": [190, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p21", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the [E1]Rho[/E1] signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to [E2]actin[/E2]-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[65, 68]], "entity_1_idx_in_text_with_entity_marker": [69, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p22", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of [E1]PLC-delta[/E1], which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to [E2]actin binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC-delta", "entity_1_idx": [[160, 169]], "entity_1_idx_in_text_with_entity_marker": [164, 173], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding proteins", "entity_2_idx": [[268, 290]], "entity_2_idx_in_text_with_entity_marker": [281, 303], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p23", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to [E1]actin binding proteins[/E1] such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[268, 290]], "entity_1_idx_in_text_with_entity_marker": [272, 294], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p24", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the [E1]Rho[/E1] signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to [E2]actin binding proteins[/E2] such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[65, 68]], "entity_1_idx_in_text_with_entity_marker": [69, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding proteins", "entity_2_idx": [[268, 290]], "entity_2_idx_in_text_with_entity_marker": [281, 303], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p25", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of [E1]PLC-delta[/E1], which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC-delta", "entity_1_idx": [[160, 169]], "entity_1_idx_in_text_with_entity_marker": [164, 173], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p26", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the [E1]Rho[/E1] signalling pathway, probably downstream of Rho activation, and mediates the stimulation of [E2]PLC-delta[/E2], which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[65, 68]], "entity_1_idx_in_text_with_entity_marker": [69, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PLC-delta", "entity_2_idx": [[160, 169]], "entity_2_idx_in_text_with_entity_marker": [173, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d698.s0_BioInfer.d698.s0.p27", "text": "These findings suggest that this novel RhoGAP is involved in the Rho signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and profilin.", "text_with_entity_marker": "These findings suggest that this novel RhoGAP is involved in the [E1]Rho[/E1] signalling pathway, probably downstream of Rho activation, and mediates the stimulation of PLC-delta, which leads to actin-related cytoskeletal changes through the hydrolysis of PIP2, which binds to actin binding proteins such as gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[65, 68]], "entity_1_idx_in_text_with_entity_marker": [69, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[312, 320]], "entity_2_idx_in_text_with_entity_marker": [325, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s1_BioInfer.d570.s1.p0", "text": "The interactions of yeast and human platelet profilins with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "text_with_entity_marker": "The interactions of yeast and human platelet [E1]profilins[/E1] with rabbit [E2]skeletal muscle actin[/E2] were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[45, 54]], "entity_1_idx_in_text_with_entity_marker": [49, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[67, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s1_BioInfer.d570.s1.p1", "text": "The interactions of yeast and human platelet profilins with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "text_with_entity_marker": "The interactions of yeast and human [E1]platelet [E2]profilins[/E1-E2] with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "platelet [E2]profilins", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[45, 54]], "entity_2_idx_in_text_with_entity_marker": [53, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s1_BioInfer.d570.s1.p2", "text": "The interactions of yeast and human platelet profilins with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "text_with_entity_marker": "The interactions of yeast and human [E1]platelet profilins[/E1] with rabbit [E2]skeletal muscle actin[/E2] were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "platelet profilins", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[67, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s2_BioInfer.d570.s2.p0", "text": "The in vivo and in vitro properties of yeast profilin mutants with altered poly-L-proline and actin binding sites are discussed in the context of the crystal structure.", "text_with_entity_marker": "The in vivo and in vitro properties of yeast [E1]profilin[/E1] mutants with altered poly-L-proline and [E2]actin[/E2] binding sites are discussed in the context of the crystal structure.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p0", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit [E1]skeletal actin[/E1] with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal actin", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p1", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit [E1]skeletal actin[/E1] with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast [E2]profilin[/E2] and pyrene-labeled yeast actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "skeletal actin", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[168, 176]], "entity_2_idx_in_text_with_entity_marker": [181, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p2", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit [E1]skeletal actin[/E1] with human [E2]profilin[/E2] yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "skeletal actin", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p3", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast [E1]profilin[/E1] and pyrene-labeled yeast [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[168, 176]], "entity_1_idx_in_text_with_entity_marker": [172, 180], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p4", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit skeletal actin with human [E1]profilin[/E1] yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p5", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit skeletal actin with human [E1]profilin[/E1] yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast [E2]profilin[/E2] and pyrene-labeled yeast actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[168, 176]], "entity_2_idx_in_text_with_entity_marker": [181, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p0", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p1", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, and [E2]zyxin[/E2], but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "zyxin", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p2", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p3", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p4", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], and [E2]zyxin[/E2], but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[111, 122]], "entity_1_idx_in_text_with_entity_marker": [115, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "zyxin", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p5", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p6", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p7", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and [E2]zyxin[/E2], but none was identified at the host-parasite junction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "zyxin", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p8", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link actin filaments to membrane were also examined, including [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, and [E2]zyxin[/E2], but none was identified at the host-parasite junction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "zyxin", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p9", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p0", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including [E2]vinculin[/E2], talin, and ezrin, are not present.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p1", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other actin-associated proteins, including [E1]vinculin[/E1], talin, and [E2]ezrin[/E2], are not present.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ezrin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p2", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other actin-associated proteins, including [E1]vinculin[/E1], [E2]talin[/E2], and ezrin, are not present.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p3", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including vinculin, talin, and [E2]ezrin[/E2], are not present.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ezrin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p4", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including vinculin, [E2]talin[/E2], and ezrin, are not present.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p5", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other actin-associated proteins, including vinculin, [E1]talin[/E1], and [E2]ezrin[/E2], are not present.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ezrin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p0", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins vinculin, talin and [E2]paxillin[/E2] in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p1", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins vinculin, [E2]talin[/E2] and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p2", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of [E1]actin[/E1]-anchoring proteins [E2]vinculin[/E2], talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[62, 70]], "entity_2_idx_in_text_with_entity_marker": [75, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p3", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of actin-anchoring proteins vinculin, [E1]talin[/E1] and [E2]paxillin[/E2] in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p4", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of actin-anchoring proteins [E1]vinculin[/E1], talin and [E2]paxillin[/E2] in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d292.s0_BioInfer.d292.s0.p5", "text": "Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "text_with_entity_marker": "Immunohistochemical investigation of actin-anchoring proteins [E1]vinculin[/E1], [E2]talin[/E2] and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p20", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E1]CDK2[/E1] (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p21", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p22", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p23", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p24", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p25", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p26", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p27", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with [E2]cyclin E[/E2]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[199, 207]], "entity_2_idx_in_text_with_entity_marker": [212, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p28", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of [E2]p27[/E2] with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p29", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E2]kinase[/E2] activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "kinase", "entity_2_idx": [[242, 248]], "entity_2_idx_in_text_with_entity_marker": [255, 261], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s0_BioInfer.d175.s0.p0", "text": "Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.", "text_with_entity_marker": "Discrete segments (70-150 amino acids) of [E1]PRT1[/E1] and TIF35 were found to be responsible for their binding to [E2]TIF34[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRT1", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TIF34", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s0_BioInfer.d175.s0.p1", "text": "Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.", "text_with_entity_marker": "Discrete segments (70-150 amino acids) of [E1]PRT1[/E1] and [E2]TIF35[/E2] were found to be responsible for their binding to TIF34.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TIF35", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s0_BioInfer.d175.s0.p2", "text": "Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.", "text_with_entity_marker": "Discrete segments (70-150 amino acids) of PRT1 and [E1]TIF35[/E1] were found to be responsible for their binding to [E2]TIF34[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TIF35", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TIF34", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p0", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The [E1]PRT1[/E1], TIF34, [E2]GCD10[/E2], and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GCD10", "entity_2_idx": [[17, 22]], "entity_2_idx_in_text_with_entity_marker": [30, 35], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p1", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, [E1]GCD10[/E1], and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with [E2]eukaryotic translation initiation factor 3[/E2] (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GCD10", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eukaryotic translation initiation factor 3", "entity_2_idx": [[109, 151]], "entity_2_idx_in_text_with_entity_marker": [122, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p2", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, [E1]TIF34[/E1], [E2]GCD10[/E2], and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "GCD10", "entity_2_idx": [[17, 22]], "entity_2_idx_in_text_with_entity_marker": [30, 35], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p3", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, [E1]GCD10[/E1], and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 ([E2]eIF3[/E2]) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GCD10", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eIF3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p4", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, [E1]GCD10[/E1], and [E2]SUI1[/E2] proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GCD10", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SUI1", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p5", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The [E1]PRT1[/E1], TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with [E2]eukaryotic translation initiation factor 3[/E2] (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eukaryotic translation initiation factor 3", "entity_2_idx": [[109, 151]], "entity_2_idx_in_text_with_entity_marker": [122, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p6", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The [E1]PRT1[/E1], [E2]TIF34[/E2], GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TIF34", "entity_2_idx": [[10, 15]], "entity_2_idx_in_text_with_entity_marker": [23, 28], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p7", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The [E1]PRT1[/E1], TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 ([E2]eIF3[/E2]) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eIF3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p8", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The [E1]PRT1[/E1], TIF34, GCD10, and [E2]SUI1[/E2] proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRT1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SUI1", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p9", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, [E1]TIF34[/E1], GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with [E2]eukaryotic translation initiation factor 3[/E2] (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eukaryotic translation initiation factor 3", "entity_2_idx": [[109, 151]], "entity_2_idx_in_text_with_entity_marker": [122, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p10", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with [E1]eukaryotic translation initiation factor 3[/E1] ([E2]eIF3[/E2]) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "eukaryotic translation initiation factor 3", "entity_1_idx": [[109, 151]], "entity_1_idx_in_text_with_entity_marker": [113, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "eIF3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p11", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, GCD10, and [E1]SUI1[/E1] proteins of Saccharomyces cerevisiae were found previously to copurify with [E2]eukaryotic translation initiation factor 3[/E2] (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SUI1", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eukaryotic translation initiation factor 3", "entity_2_idx": [[109, 151]], "entity_2_idx_in_text_with_entity_marker": [122, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p12", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, [E1]TIF34[/E1], GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 ([E2]eIF3[/E2]) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eIF3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p13", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, [E1]TIF34[/E1], GCD10, and [E2]SUI1[/E2] proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TIF34", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SUI1", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d175.s1_BioInfer.d175.s1.p14", "text": "The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.", "text_with_entity_marker": "The PRT1, TIF34, GCD10, and [E1]SUI1[/E1] proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 ([E2]eIF3[/E2]) activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SUI1", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "eIF3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d500.s0_BioInfer.d500.s0.p0", "text": "Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.", "text_with_entity_marker": "Proteolytic activity was not detected with casein, [E1]actin[/E1], or [E2]myosin heavy-chain[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy-chain", "entity_2_idx": [[61, 79]], "entity_2_idx_in_text_with_entity_marker": [74, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d500.s0_BioInfer.d500.s0.p1", "text": "Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.", "text_with_entity_marker": "Proteolytic activity was not detected with [E1]casein[/E1], [E2]actin[/E2], or myosin heavy-chain substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "casein", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d500.s0_BioInfer.d500.s0.p2", "text": "Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.", "text_with_entity_marker": "Proteolytic activity was not detected with [E1]casein[/E1], actin, or [E2]myosin heavy-chain[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "casein", "entity_1_idx": [[43, 49]], "entity_1_idx_in_text_with_entity_marker": [47, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy-chain", "entity_2_idx": [[61, 79]], "entity_2_idx_in_text_with_entity_marker": [74, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d739.s0_BioInfer.d739.s0.p0", "text": "This filament growth is driven by a large storage pool of actin bound to the sequestering protein, profilin.", "text_with_entity_marker": "This filament growth is driven by a large storage pool of [E1]actin[/E1] bound to the sequestering protein, [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d724.s0_BioInfer.d724.s0.p0", "text": "The structure of an actin-crosslinking domain from human fimbrin.", "text_with_entity_marker": "The structure of an [E1]actin[/E1]-crosslinking domain from human [E2]fimbrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[57, 64]], "entity_2_idx_in_text_with_entity_marker": [70, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p0", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 [E1]primosome[/E1] consists of three subunits that are the products of the [E2]UL5[/E2], UL8, and UL52 genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "primosome", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p1", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p2", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p3", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 [E1]primosome[/E1] consists of three subunits that are the products of the UL5, [E2]UL8[/E2], and UL52 genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "primosome", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p4", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 [E1]primosome[/E1] consists of three subunits that are the products of the UL5, UL8, and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "primosome", "entity_1_idx": [[32, 41]], "entity_1_idx_in_text_with_entity_marker": [36, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d621.s0_BioInfer.d621.s0.p5", "text": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.", "text_with_entity_marker": "The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[103, 106]], "entity_1_idx_in_text_with_entity_marker": [107, 110], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p0", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases PP1 and PP2A associate with and activate the [E1]actin-binding protein[/E1] [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[69, 90]], "entity_1_idx_in_text_with_entity_marker": [73, 94], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p1", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases [E1]PP1[/E1] and PP2A associate with and activate the [E2]actin-binding protein[/E2] cofilin in human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PP1", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[69, 90]], "entity_2_idx_in_text_with_entity_marker": [82, 103], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p2", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases PP1 and [E1]PP2A[/E1] associate with and activate the [E2]actin-binding protein[/E2] cofilin in human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PP2A", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[69, 90]], "entity_2_idx_in_text_with_entity_marker": [82, 103], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p3", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The [E1]serine phosphatases[/E1] PP1 and PP2A associate with and activate the [E2]actin-binding protein[/E2] cofilin in human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "serine phosphatases", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin-binding protein", "entity_2_idx": [[69, 90]], "entity_2_idx_in_text_with_entity_marker": [82, 103], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p4", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases [E1]PP1[/E1] and PP2A associate with and activate the actin-binding protein [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PP1", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p5", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases PP1 and [E1]PP2A[/E1] associate with and activate the actin-binding protein [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PP2A", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p6", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The [E1]serine phosphatases[/E1] PP1 and PP2A associate with and activate the actin-binding protein [E2]cofilin[/E2] in human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "serine phosphatases", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p7", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The serine phosphatases [E1]PP1[/E1] and [E2]PP2A[/E2] associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PP1", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PP2A", "entity_2_idx": [[32, 36]], "entity_2_idx_in_text_with_entity_marker": [45, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p8", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The [E1]serine phosphatases[/E1] [E2]PP1[/E2] and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "serine phosphatases", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "PP1", "entity_2_idx": [[24, 27]], "entity_2_idx_in_text_with_entity_marker": [37, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d716.s0_BioInfer.d716.s0.p9", "text": "The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "text_with_entity_marker": "The [E1]serine phosphatases[/E1] PP1 and [E2]PP2A[/E2] associate with and activate the actin-binding protein cofilin in human T lymphocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "serine phosphatases", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "PP2A", "entity_2_idx": [[32, 36]], "entity_2_idx_in_text_with_entity_marker": [45, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d168.s0_BioInfer.d168.s0.p0", "text": "Demembranated stereociliary cores consisted primarily of protein bands corresponding to actin and fimbrin and several proteins ranging from 43 to 63 kDa.", "text_with_entity_marker": "Demembranated stereociliary cores consisted primarily of protein bands corresponding to [E1]actin[/E1] and [E2]fimbrin[/E2] and several proteins ranging from 43 to 63 kDa.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[88, 93]], "entity_1_idx_in_text_with_entity_marker": [92, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s0_BioInfer.d505.s0.p0", "text": "Pyrenyliodoacetamide labeling of cysteine 374 of muscle actin reduces the affinity for profilin 10-fold.", "text_with_entity_marker": "Pyrenyliodoacetamide labeling of cysteine 374 of [E1]muscle actin[/E1] reduces the affinity for [E2]profilin[/E2] 10-fold.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "muscle actin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[87, 95]], "entity_2_idx_in_text_with_entity_marker": [100, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s1_BioInfer.d505.s1.p0", "text": "Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of profilin for actin.", "text_with_entity_marker": "Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of [E1]profilin[/E1] for [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[121, 129]], "entity_1_idx_in_text_with_entity_marker": [125, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s2_BioInfer.d505.s2.p0", "text": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.", "text_with_entity_marker": "Three methods, fluorescence anisotropy of rhodamine-labeled [E1]profilin[/E1], intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba [E2]actin[/E2] monomers with bound Mg-ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s2_BioInfer.d505.s2.p1", "text": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.", "text_with_entity_marker": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba [E1]profilins[/E1] binding amoeba [E2]actin[/E2] monomers with bound Mg-ATP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[176, 185]], "entity_1_idx_in_text_with_entity_marker": [180, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s2_BioInfer.d505.s2.p2", "text": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.", "text_with_entity_marker": "Three methods, fluorescence anisotropy of rhodamine-labeled [E1]profilin[/E1], intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba [E2]profilins[/E2] binding amoeba actin monomers with bound Mg-ATP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[176, 185]], "entity_2_idx_in_text_with_entity_marker": [189, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d11.s0_BioInfer.d11.s0.p0", "text": "A common feature of these talin-positive domains is the deep membrane infoldings, where bundles of actin filaments are inserted into the membrane.", "text_with_entity_marker": "A common feature of these [E1]talin[/E1]-positive domains is the deep membrane infoldings, where bundles of [E2]actin[/E2] filaments are inserted into the membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d173.s0_BioInfer.d173.s0.p0", "text": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.", "text_with_entity_marker": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of [E1]myosin heavy chain[/E1] and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[89, 107]], "entity_1_idx_in_text_with_entity_marker": [93, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d173.s0_BioInfer.d173.s0.p1", "text": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.", "text_with_entity_marker": "Digestion of isolated myofibrils with [E1]alkaline proteinase[/E1] resulted in the degradation of [E2]myosin heavy chain[/E2] and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alkaline proteinase", "entity_1_idx": [[38, 57]], "entity_1_idx_in_text_with_entity_marker": [42, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[89, 107]], "entity_2_idx_in_text_with_entity_marker": [102, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d173.s0_BioInfer.d173.s0.p2", "text": "Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.", "text_with_entity_marker": "Digestion of isolated myofibrils with [E1]alkaline proteinase[/E1] resulted in the degradation of myosin heavy chain and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alkaline proteinase", "entity_1_idx": [[38, 57]], "entity_1_idx_in_text_with_entity_marker": [42, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p0", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "[E1]Death receptors[/E1] belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as [E2]Caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Death receptors", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p1", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "[E1]Death receptors[/E1] belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as [E2]TRADD[/E2] and FADD and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Death receptors", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[153, 158]], "entity_2_idx_in_text_with_entity_marker": [166, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p2", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "[E1]Death receptors[/E1] belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and [E2]FADD[/E2] and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Death receptors", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p3", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "[E1]Death receptors[/E1] belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and [E2]cysteine proteases[/E2] such as Caspase-8.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Death receptors", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cysteine proteases", "entity_2_idx": [[172, 190]], "entity_2_idx_in_text_with_entity_marker": [185, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p4", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "[E1]Death receptors[/E1] belong to the [E2]TNF receptor[/E2] family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Death receptors", "entity_1_idx": [[0, 15]], "entity_1_idx_in_text_with_entity_marker": [4, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[30, 42]], "entity_2_idx_in_text_with_entity_marker": [43, 55], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p5", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as [E1]TRADD[/E1] and FADD and cysteine proteases such as [E2]Caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[153, 158]], "entity_1_idx_in_text_with_entity_marker": [157, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p6", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and [E1]FADD[/E1] and cysteine proteases such as [E2]Caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p7", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and [E1]cysteine proteases[/E1] such as [E2]Caspase-8[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cysteine proteases", "entity_1_idx": [[172, 190]], "entity_1_idx_in_text_with_entity_marker": [176, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p8", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the [E1]TNF receptor[/E1] family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as [E2]Caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[30, 42]], "entity_1_idx_in_text_with_entity_marker": [34, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p9", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as [E1]TRADD[/E1] and [E2]FADD[/E2] and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[153, 158]], "entity_1_idx_in_text_with_entity_marker": [157, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p10", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as [E1]TRADD[/E1] and FADD and [E2]cysteine proteases[/E2] such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[153, 158]], "entity_1_idx_in_text_with_entity_marker": [157, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cysteine proteases", "entity_2_idx": [[172, 190]], "entity_2_idx_in_text_with_entity_marker": [185, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p11", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the [E1]TNF receptor[/E1] family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as [E2]TRADD[/E2] and FADD and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[30, 42]], "entity_1_idx_in_text_with_entity_marker": [34, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "TRADD", "entity_2_idx": [[153, 158]], "entity_2_idx_in_text_with_entity_marker": [166, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p12", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and [E1]FADD[/E1] and [E2]cysteine proteases[/E2] such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[163, 167]], "entity_1_idx_in_text_with_entity_marker": [167, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cysteine proteases", "entity_2_idx": [[172, 190]], "entity_2_idx_in_text_with_entity_marker": [185, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p13", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the [E1]TNF receptor[/E1] family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and [E2]FADD[/E2] and cysteine proteases such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[30, 42]], "entity_1_idx_in_text_with_entity_marker": [34, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "FADD", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d164.s0_BioInfer.d164.s0.p14", "text": "Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.", "text_with_entity_marker": "Death receptors belong to the [E1]TNF receptor[/E1] family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and [E2]cysteine proteases[/E2] such as Caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[30, 42]], "entity_1_idx_in_text_with_entity_marker": [34, 46], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cysteine proteases", "entity_2_idx": [[172, 190]], "entity_2_idx_in_text_with_entity_marker": [185, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p1", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E1]MSH6[/E1] or [E2]MSH2[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[272, 276]], "entity_2_idx_in_text_with_entity_marker": [285, 289], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p2", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or [E1]MSH2[/E1] and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[272, 276]], "entity_1_idx_in_text_with_entity_marker": [276, 280], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p3", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires [E1]MSH2[/E1] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or [E2]MSH2[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[272, 276]], "entity_2_idx_in_text_with_entity_marker": [285, 289], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p4", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E1]MSH6[/E1], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or [E2]MSH2[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[155, 159]], "entity_1_idx_in_text_with_entity_marker": [159, 163], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[272, 276]], "entity_2_idx_in_text_with_entity_marker": [285, 289], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p5", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or [E2]MSH2[/E2] and MSH3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[272, 276]], "entity_2_idx_in_text_with_entity_marker": [285, 289], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p6", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either [E1]MSH2[/E1] and [E2]MSH6[/E2] or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[255, 259]], "entity_1_idx_in_text_with_entity_marker": [259, 263], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p7", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either [E1]MSH2[/E1] and MSH6 or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[255, 259]], "entity_1_idx_in_text_with_entity_marker": [259, 263], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p8", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires [E1]MSH2[/E1] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either [E2]MSH2[/E2] and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[255, 259]], "entity_2_idx_in_text_with_entity_marker": [268, 272], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p9", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E1]MSH6[/E1], and a second that recognizes insertion/deletion mispairs and requires a combination of either [E2]MSH2[/E2] and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[155, 159]], "entity_1_idx_in_text_with_entity_marker": [159, 163], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[255, 259]], "entity_2_idx_in_text_with_entity_marker": [268, 272], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p10", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either [E2]MSH2[/E2] and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[255, 259]], "entity_2_idx_in_text_with_entity_marker": [268, 272], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p11", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E1]MSH6[/E1] or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p12", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires [E1]MSH2[/E1] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E2]MSH6[/E2] or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p13", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E1]MSH6[/E1], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E2]MSH6[/E2] or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[155, 159]], "entity_1_idx_in_text_with_entity_marker": [159, 163], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p14", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E2]MSH6[/E2] or MSH2 and MSH3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p15", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires [E1]MSH2[/E1] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p16", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E1]MSH6[/E1], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[155, 159]], "entity_1_idx_in_text_with_entity_marker": [159, 163], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p17", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p18", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires [E1]MSH2[/E1] and [E2]MSH6[/E2], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[155, 159]], "entity_2_idx_in_text_with_entity_marker": [168, 172], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p19", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires [E2]MSH2[/E2] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p20", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E2]MSH6[/E2], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[155, 159]], "entity_2_idx_in_text_with_entity_marker": [168, 172], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p0", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p1", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p2", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p3", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p4", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase ([E2]HN[/E2]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[213, 215]], "entity_2_idx_in_text_with_entity_marker": [226, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p5", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] ([E2]L[/E2]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[170, 171]], "entity_2_idx_in_text_with_entity_marker": [183, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p6", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p7", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), [E2]haemagglutinin neuraminidase[/E2] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin neuraminidase", "entity_2_idx": [[183, 211], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [196, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p8", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p9", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d674.s0_BioInfer.d674.s0.p0", "text": "The protein has the two conserved domains identified as actin and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the cofilin family.", "text_with_entity_marker": "The protein has the two conserved domains identified as [E1]actin[/E1] and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the [E2]cofilin[/E2] family.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[148, 155]], "entity_2_idx_in_text_with_entity_marker": [161, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p0", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, [E1]MEC1[/E1], MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p1", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p2", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p3", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, [E1]MEC3[/E1] and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p4", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p5", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p6", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p7", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, [E1]MEC1[/E1], [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p8", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p9", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, [E2]RAD17[/E2], MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p10", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p11", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], [E2]RAD17[/E2], MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p12", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p13", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], [E2]RAD24[/E2], RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p14", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d532.s0_BioInfer.d532.s0.p0", "text": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "text_with_entity_marker": "Ser-133 phosphorylation enhances [E1]CREB[/E1] activity by promoting interaction with a 265-kDa CREB binding protein referred to as [E2]CBP[/E2] (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d532.s0_BioInfer.d532.s0.p1", "text": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "text_with_entity_marker": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa [E1]CREB binding protein[/E1] referred to as [E2]CBP[/E2] (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB binding protein", "entity_1_idx": [[87, 107]], "entity_1_idx_in_text_with_entity_marker": [91, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d532.s0_BioInfer.d532.s0.p2", "text": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "text_with_entity_marker": "Ser-133 phosphorylation enhances [E1]CREB[/E1] activity by promoting interaction with a 265-kDa [E2]CREB binding protein[/E2] referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB binding protein", "entity_2_idx": [[87, 107]], "entity_2_idx_in_text_with_entity_marker": [100, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p30", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p31", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p32", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p33", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/[E2]WSC1[/E2]/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "WSC1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p34", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p35", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p36", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or [E2]MPK1[/E2] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MPK1", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p37", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p38", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p39", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p60", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, [E2]RHO2[/E2], HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RHO2", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p61", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p62", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p63", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p64", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p65", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p66", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p67", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p68", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p69", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E2]Pkc1p[/E2] pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "Pkc1p", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p0", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E1]actin[/E1] monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p1", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length [E1]Scar[/E1], Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E2]actin[/E2] monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p2", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E2]actin[/E2] monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p3", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, [E1]Scar[/E1] containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E2]actin[/E2] monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p4", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or [E1]Scar[/E1] containing W and A domains overcomes inhibition of nucleation by the [E2]actin[/E2] monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p5", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E2]actin[/E2] monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p6", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length [E1]Scar[/E1], Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p7", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p8", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, [E1]Scar[/E1] containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p9", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or [E1]Scar[/E1] containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p10", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p11", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length [E2]Scar[/E2], Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [49, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p12", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length [E1]Scar[/E1], [E2]Scar[/E2] containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[42, 46]], "entity_2_idx_in_text_with_entity_marker": [55, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p13", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length [E1]Scar[/E1], Scar containing P, W, and A domains, or [E2]Scar[/E2] containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p14", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length [E2]Scar[/E2], Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [49, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p15", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length Scar, [E2]Scar[/E2] containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[42, 46]], "entity_2_idx_in_text_with_entity_marker": [55, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p16", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length Scar, Scar containing P, W, and A domains, or [E2]Scar[/E2] containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p17", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1-E2]Arp[/E1]2[/E2]/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [11, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[4, 8]], "entity_2_idx_in_text_with_entity_marker": [11, 20], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p18", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, [E1]Scar[/E1] containing P, W, and A domains, or [E2]Scar[/E2] containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Scar", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p19", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length Scar, [E2]Scar[/E2] containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[42, 46]], "entity_2_idx_in_text_with_entity_marker": [55, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p20", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length Scar, Scar containing P, W, and A domains, or [E2]Scar[/E2] containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Scar", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p20", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p21", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E1]WAF1[/E1]), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WAF1", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p22", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E1]cyclin E[/E1]-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[158, 166]], "entity_1_idx_in_text_with_entity_marker": [162, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p23", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p24", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p25", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1](Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p26", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E1]WAF1[/E1]), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WAF1", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p27", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p28", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p29", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1](Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p0", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and [E1]CD44[/E1], with additional reverse transcription-[E2]polymerase[/E2] chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44", "entity_1_idx": [[231, 235]], "entity_1_idx_in_text_with_entity_marker": [235, 239], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[275, 285]], "entity_2_idx_in_text_with_entity_marker": [288, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p1", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]CD44[/E2], with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[198, 211]], "entity_1_idx_in_text_with_entity_marker": [202, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p2", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of [E1]cell adhesion molecules[/E1] and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and [E2]CD44[/E2], with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cell adhesion molecules", "entity_1_idx": [[60, 83]], "entity_1_idx_in_text_with_entity_marker": [64, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p3", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]CD44[/E2], with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[186, 196]], "entity_1_idx_in_text_with_entity_marker": [190, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p4", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]CD44[/E2], with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[213, 225]], "entity_1_idx_in_text_with_entity_marker": [217, 229], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p5", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and CD44, with additional reverse transcription-[E2]polymerase[/E2] chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[198, 211]], "entity_1_idx_in_text_with_entity_marker": [202, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[275, 285]], "entity_2_idx_in_text_with_entity_marker": [288, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p6", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of [E1]cell adhesion molecules[/E1] and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-[E2]polymerase[/E2] chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cell adhesion molecules", "entity_1_idx": [[60, 83]], "entity_1_idx_in_text_with_entity_marker": [64, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[275, 285]], "entity_2_idx_in_text_with_entity_marker": [288, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p7", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-[E2]polymerase[/E2] chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[186, 196]], "entity_1_idx_in_text_with_entity_marker": [190, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[275, 285]], "entity_2_idx_in_text_with_entity_marker": [288, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p8", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and CD44, with additional reverse transcription-[E2]polymerase[/E2] chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[213, 225]], "entity_1_idx_in_text_with_entity_marker": [217, 229], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "polymerase", "entity_2_idx": [[275, 285]], "entity_2_idx_in_text_with_entity_marker": [288, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p9", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of [E1]cell adhesion molecules[/E1] and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cell adhesion molecules", "entity_1_idx": [[60, 83]], "entity_1_idx_in_text_with_entity_marker": [64, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[198, 211]], "entity_2_idx_in_text_with_entity_marker": [211, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p10", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[186, 196]], "entity_1_idx_in_text_with_entity_marker": [190, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[198, 211]], "entity_2_idx_in_text_with_entity_marker": [211, 224], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p11", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[198, 211]], "entity_1_idx_in_text_with_entity_marker": [202, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[213, 225]], "entity_2_idx_in_text_with_entity_marker": [226, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p12", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of [E1]cell adhesion molecules[/E1] and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cell adhesion molecules", "entity_1_idx": [[60, 83]], "entity_1_idx_in_text_with_entity_marker": [64, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[186, 196]], "entity_2_idx_in_text_with_entity_marker": [199, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p13", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of [E1]cell adhesion molecules[/E1] and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cell adhesion molecules", "entity_1_idx": [[60, 83]], "entity_1_idx_in_text_with_entity_marker": [64, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[213, 225]], "entity_2_idx_in_text_with_entity_marker": [226, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d763.s0_BioInfer.d763.s0.p14", "text": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "text_with_entity_marker": "To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[186, 196]], "entity_1_idx_in_text_with_entity_marker": [190, 200], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[213, 225]], "entity_2_idx_in_text_with_entity_marker": [226, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s0_BioInfer.d151.s0.p0", "text": "CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.", "text_with_entity_marker": "CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by [E1]cofilin[/E1] and [E2]Aip1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[91, 98]], "entity_1_idx_in_text_with_entity_marker": [95, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s0_BioInfer.d151.s0.p1", "text": "CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.", "text_with_entity_marker": "CONCLUSIONS: These results suggest the cooperative modulation of the [E1]actin[/E1] cytoskeleton by cofilin and [E2]Aip1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s0_BioInfer.d151.s0.p2", "text": "CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.", "text_with_entity_marker": "CONCLUSIONS: These results suggest the cooperative modulation of the [E1]actin[/E1] cytoskeleton by [E2]cofilin[/E2] and Aip1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[91, 98]], "entity_2_idx_in_text_with_entity_marker": [104, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p0", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical [E1]actin[/E1] patches where [E2]cofilin[/E2] was also co-localized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p1", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that [E1]Aip1[/E1] was distributed in cortical [E2]actin[/E2] patches where cofilin was also co-localized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Aip1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p2", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-[E1]Aip1[/E1] antibodies revealed that Aip1 was distributed in cortical [E2]actin[/E2] patches where cofilin was also co-localized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p3", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that [E1]Aip1[/E1] was distributed in cortical actin patches where [E2]cofilin[/E2] was also co-localized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p4", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-[E1]Aip1[/E1] antibodies revealed that Aip1 was distributed in cortical actin patches where [E2]cofilin[/E2] was also co-localized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d151.s1_BioInfer.d151.s1.p5", "text": "Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.", "text_with_entity_marker": "Immunofluorescence staining of a wild-type strain using anti-[E1]Aip1[/E1] antibodies revealed that [E2]Aip1[/E2] was distributed in cortical actin patches where cofilin was also co-localized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Aip1", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Aip1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p0", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the [E1]Fas[/E1]-associated protein FADD/MORT1 or the TNF receptor-associated protein [E2]TRADD[/E2] [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[239, 242]], "entity_1_idx_in_text_with_entity_marker": [243, 246], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p1", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the [E1]Fas[/E1]-associated protein FADD/MORT1 or the [E2]TNF receptor[/E2]-associated protein TRADD [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[239, 242]], "entity_1_idx_in_text_with_entity_marker": [243, 246], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[280, 292]], "entity_2_idx_in_text_with_entity_marker": [293, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p2", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the [E1]Fas[/E1]-associated protein FADD/[E2]MORT1[/E2] or the TNF receptor-associated protein TRADD [2-4].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[239, 242]], "entity_1_idx_in_text_with_entity_marker": [243, 246], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[267, 272]], "entity_2_idx_in_text_with_entity_marker": [280, 285], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p3", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the [E1]Fas[/E1]-associated protein [E2]FADD[/E2]/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[239, 242]], "entity_1_idx_in_text_with_entity_marker": [243, 246], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p4", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the [E1]TNF receptor[/E1]-associated protein [E2]TRADD[/E2] [2-4].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF receptor", "entity_1_idx": [[280, 292]], "entity_1_idx_in_text_with_entity_marker": [284, 296], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p5", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/[E1]MORT1[/E1] or the TNF receptor-associated protein [E2]TRADD[/E2] [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[267, 272]], "entity_1_idx_in_text_with_entity_marker": [271, 276], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p6", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein [E1]FADD[/E1]/MORT1 or the TNF receptor-associated protein [E2]TRADD[/E2] [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p7", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/[E1]MORT1[/E1] or the [E2]TNF receptor[/E2]-associated protein TRADD [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[267, 272]], "entity_1_idx_in_text_with_entity_marker": [271, 276], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[280, 292]], "entity_2_idx_in_text_with_entity_marker": [293, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p8", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein [E1]FADD[/E1]/MORT1 or the [E2]TNF receptor[/E2]-associated protein TRADD [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[280, 292]], "entity_2_idx_in_text_with_entity_marker": [293, 305], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d369.s0_BioInfer.d369.s0.p9", "text": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein FADD/MORT1 or the TNF receptor-associated protein TRADD [2-4].", "text_with_entity_marker": "In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the Fas-associated protein [E1]FADD[/E1]/[E2]MORT1[/E2] or the TNF receptor-associated protein TRADD [2-4].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[267, 272]], "entity_2_idx_in_text_with_entity_marker": [280, 285], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p0", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either histone H3 or [E1]histone[/E1] [E2]H4[/E2] allowed these polyamides to bind.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[68, 70]], "entity_2_idx_in_text_with_entity_marker": [81, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p1", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either [E1]histone[/E1] H3 or histone [E2]H4[/E2] allowed these polyamides to bind.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[68, 70]], "entity_2_idx_in_text_with_entity_marker": [81, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p2", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either histone [E1]H3[/E1] or histone [E2]H4[/E2] allowed these polyamides to bind.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[54, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[68, 70]], "entity_2_idx_in_text_with_entity_marker": [81, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p3", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either [E1]histone[/E1] H3 or [E2]histone[/E2] H4 allowed these polyamides to bind.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p4", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either histone [E1]H3[/E1] or [E2]histone[/E2] H4 allowed these polyamides to bind.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[54, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d518.s0_BioInfer.d518.s0.p5", "text": "Removal of the amino-terminal tails of either histone H3 or histone H4 allowed these polyamides to bind.", "text_with_entity_marker": "Removal of the amino-terminal tails of either [E1]histone[/E1] [E2]H3[/E2] or histone H4 allowed these polyamides to bind.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[54, 56]], "entity_2_idx_in_text_with_entity_marker": [67, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d193.s0_BioInfer.d193.s0.p0", "text": "Evaluation of the binding of Acanthamoeba profilin to pyrene-labeled actin by fluorescence enhancement.", "text_with_entity_marker": "Evaluation of the binding of Acanthamoeba [E1]profilin[/E1] to pyrene-labeled [E2]actin[/E2] by fluorescence enhancement.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p0", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of [E1]cyclin E[/E1], a G1 cyclin, and [E2]p27kip[/E2], a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27kip", "entity_2_idx": [[57, 63]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p1", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of cyclin E, a [E1]G1 cyclin[/E1], and [E2]p27kip[/E2], a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G1 cyclin", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27kip", "entity_2_idx": [[57, 63]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p2", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of cyclin E, a G1 cyclin, and [E1]p27kip[/E1], a [E2]cyclin-dependent kinase inhibitor[/E2], in BALB/c 3T3 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27kip", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[67, 100]], "entity_2_idx_in_text_with_entity_marker": [80, 113], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p3", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of [E1]cyclin E[/E1], a [E2]G1 cyclin[/E2], and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G1 cyclin", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p4", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of [E1]cyclin E[/E1], a G1 cyclin, and p27kip, a [E2]cyclin-dependent kinase inhibitor[/E2], in BALB/c 3T3 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[67, 100]], "entity_2_idx_in_text_with_entity_marker": [80, 113], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p5", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of cyclin E, a [E1]G1 cyclin[/E1], and p27kip, a [E2]cyclin-dependent kinase inhibitor[/E2], in BALB/c 3T3 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G1 cyclin", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[67, 100]], "entity_2_idx_in_text_with_entity_marker": [80, 113], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p30", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that [E1]pRb[/E1] causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27([E2]KIP1[/E2]) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pRb", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p31", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which [E1]pRb[/E1] induces senescence, we have found that [E2]pRb[/E2] causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pRb", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p32", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that [E1]pRb[/E1] causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p33", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which [E1]pRb[/E1] induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27([E2]KIP1[/E2]) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "KIP1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p34", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27([E1]KIP1[/E1]) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "KIP1", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p35", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which [E1]pRb[/E1] induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p50", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p51", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p52", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p53", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p54", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p55", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p56", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p57", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p58", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p59", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p120", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p121", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), [E2]ribonucleotide reductase[/E2] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ribonucleotide reductase", "entity_2_idx": [[118, 142]], "entity_2_idx_in_text_with_entity_marker": [131, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p122", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p123", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p124", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), [E2]proliferating cell nuclear antigen[/E2] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p125", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p126", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p127", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p128", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), [E2]proliferating cell nuclear antigen[/E2] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[150, 184]], "entity_2_idx_in_text_with_entity_marker": [163, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p129", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d58.s0_BioInfer.d58.s0.p0", "text": "Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of profilin and actin did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.", "text_with_entity_marker": "Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of [E1]profilin[/E1] and [E2]actin[/E2] did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[75, 83]], "entity_1_idx_in_text_with_entity_marker": [79, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d63.s0_BioInfer.d63.s0.p0", "text": "An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "text_with_entity_marker": "An association was seen between E-cadherin and [E1]alpha-catenin[/E1] expression, in both effusions and solid tumours, and for [E2]beta-catenin[/E2] in solid tumours (range p<0. 001 to p=0.014).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[118, 130]], "entity_2_idx_in_text_with_entity_marker": [131, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d63.s0_BioInfer.d63.s0.p1", "text": "An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "text_with_entity_marker": "An association was seen between [E1]E-cadherin[/E1] and alpha-catenin expression, in both effusions and solid tumours, and for [E2]beta-catenin[/E2] in solid tumours (range p<0. 001 to p=0.014).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[32, 42]], "entity_1_idx_in_text_with_entity_marker": [36, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[118, 130]], "entity_2_idx_in_text_with_entity_marker": [131, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d63.s0_BioInfer.d63.s0.p2", "text": "An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "text_with_entity_marker": "An association was seen between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[32, 42]], "entity_1_idx_in_text_with_entity_marker": [36, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p0", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The [E1]adenosine deaminase[/E1]-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV([E2]CD26[/E2]) molecule.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD26", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p1", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The [E1]adenosine deaminase[/E1]-binding region is distinct from major anti-[E2]CD26[/E2] mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD26", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p2", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The [E1]adenosine deaminase[/E1]-binding region is distinct from major anti-CD26 mAb epitopes on the human [E2]dipeptidyl peptidase IV[/E2](CD26) molecule.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[4, 23]], "entity_1_idx_in_text_with_entity_marker": [8, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[98, 121]], "entity_2_idx_in_text_with_entity_marker": [111, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p3", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The adenosine deaminase-binding region is distinct from major anti-[E1]CD26[/E1] mAb epitopes on the human dipeptidyl peptidase IV([E2]CD26[/E2]) molecule.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p4", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human [E1]dipeptidyl peptidase IV[/E1]([E2]CD26[/E2]) molecule.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[98, 121]], "entity_1_idx_in_text_with_entity_marker": [102, 125], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d581.s0_BioInfer.d581.s0.p5", "text": "The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.", "text_with_entity_marker": "The adenosine deaminase-binding region is distinct from major anti-[E1]CD26[/E1] mAb epitopes on the human [E2]dipeptidyl peptidase IV[/E2](CD26) molecule.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[98, 121]], "entity_2_idx_in_text_with_entity_marker": [111, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
